William W. O’neill

William W. O’neill's AcademicInfluence.com Rankings

William W. O’neill

Medical

#1245

World Rank

#1564

Historical Rank

Cardiology

#85

World Rank

#86

Historical Rank

medical Degrees

William W. O’neill

Philosophy

#4128

World Rank

#6524

Historical Rank

Logic

#1660

World Rank

#2466

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

William W. O’neill's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Sciences University of California, San Francisco

Why Is William W. O’neill Influential?

(Suggest an Edit or Addition)

(See a Problem?)

William W. O’neill's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A controlled trial of renal denervation for resistant hypertension. (2014) (1851)
Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. (1997) (1669)
Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography. (2005) (1561)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention (2006) (1467)
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. (1987) (955)
Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction (1999) (915)
2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. (2008) (872)
2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2008) (847)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). (2006) (709)
A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. (2007) (648)
Multiple complex coronary plaques in patients with acute myocardial infarction. (2000) (645)
A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary Intervention: The PROTECT II Study (2012) (606)
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. (2005) (514)
Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. (2004) (513)
A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. (2006) (510)
Normal Flow (TIMI-3) Before Mechanical Reperfusion Therapy Is an Independent Determinant of Survival in Acute Myocardial Infarction: Analysis From the Primary Angioplasty in Myocardial Infarction Trials (2001) (478)
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. (2015) (477)
Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. (2007) (437)
Impact of Sirolimus-Eluting Stents on Outcome in Diabetic Patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) Substudy (2004) (431)
SCAI clinical expert consensus statement on the classification of cardiogenic shock (2019) (419)
Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. (2000) (384)
A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. (2002) (384)
Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. (1999) (380)
Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. (1983) (377)
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. (2000) (363)
Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. (2003) (332)
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention (2006) (315)
Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. (2002) (307)
Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 Trial (2012) (306)
The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry (2013) (304)
A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy ☆: Results of the P.R.I.N.C.E. study (1999) (301)
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. (2009) (300)
Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction : In-hospital and 30-day results of the PAMI stent pilot trial (1998) (290)
Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device. (2015) (287)
Effect of reperfusion on biventricular function and survival after right ventricular infarction. (1998) (287)
Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. (1988) (284)
Features and outcome of no-reflow after percutaneous coronary intervention. (1995) (279)
The diagnostic accuracy of 64-slice computed tomography coronary angiography compared with stress nuclear imaging in emergency department low-risk chest pain patients. (2007) (277)
Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Standard Care Among Inoperable Patients With Severe Aortic Stenosis: Results From the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B) (2012) (271)
Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Results From the First Multicenter Global Registry. (2016) (256)
1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification. (2018) (252)
Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock. (2017) (249)
A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. (1997) (242)
Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction. (1998) (235)
Non–Polymer-Based Paclitaxel-Coated Coronary Stents for the Treatment of Patients With De Novo Coronary Lesions: Angiographic Follow-Up of the DELIVER Clinical Trial (2004) (228)
Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative (2019) (227)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: A report of the American college of cardiology/American heart association task force on practice guidelines(ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention) (2006) (226)
Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. (2010) (223)
Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. (2004) (222)
Application of digital techniques to selective coronary arteriography: use of myocardial contrast appearance time to measure coronary flow reserve. (1984) (213)
Iatrogenic coronary artery dissections extending into and involving the aortic root (2000) (211)
Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events. (2000) (207)
Clinical and Angiographic Predictors of Restenosis After Stent Deployment in Diabetic Patients (2004) (203)
Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). (2004) (203)
Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival. (1991) (200)
Clinical and angiographic follow-Up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial. (1999) (199)
A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. (1988) (198)
Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. (1991) (192)
Perforations after percutaneous coronary interventions: clinical, angiographic, and therapeutic observations. (1994) (191)
Usefulness of bone mineral density to predict significant coronary artery disease. (2005) (189)
Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting. (1997) (187)
Post-Approval U.S. Experience With Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation. (2017) (184)
Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. (2014) (182)
A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial. (1998) (177)
A Prospective, Placebo‐Controlled, Randomized Trial of Intravenous Streptokinase and Angioplasty Versus Lone Angioplasty Therapy of Acute Myocardial Infarction (1992) (172)
Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. (2001) (171)
One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. (2005) (169)
Transcaval Access and Closure for Transcatheter Aortic Valve Replacement: A Prospective Investigation. (2017) (168)
Regional variation across the United States in the management of acute myocardial infarction. (1995) (167)
Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial. (1999) (167)
Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients: initial human experience. (2014) (166)
Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction. (1988) (163)
Six‐Month Clinical and Angiographic Follow‐up After Direct Angioplasty for Acute Myocardial Infarction: Final Results From the Primary Angioplasty Registry (1994) (161)
Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment–Elevation Myocardial Infarction: A Pilot Study Using the Impella CP (2019) (158)
Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials). (2000) (156)
Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention. (2003) (156)
Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. (1987) (156)
Coronary angioplasty and Rotablator atherectomy trial (CARAT): Immediate and late results of a prospective multicenter randomized trial (2001) (155)
Multicenter study of percutaneous transluminal angioplasty for right coronary artery ostial stenosis. (1987) (155)
Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. (2001) (154)
Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? (2004) (154)
Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial). (2001) (152)
Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device (2018) (146)
Impact of Annual Operator and Institutional Volume on Percutaneous Coronary Intervention Outcomes: A 5-Year United States Experience (2005–2009) (2014) (144)
Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). (2005) (144)
Determinants of serum creatinine trajectory in acute contrast nephropathy. (2002) (144)
Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention (2016) (143)
Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials. (2007) (143)
Validation in dogs of a rapid digital angiographic technique to measure relative coronary blood flow during routine cardiac catheterization. (1985) (140)
Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. (2004) (140)
Characteristics of cerebrovascular accidents after percutaneous coronary interventions. (2004) (140)
Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. (1997) (140)
Intentional Percutaneous Laceration of the Anterior Mitral Leaflet to Prevent Outflow Obstruction During Transcatheter Mitral Valve Replacement: First-in-Human Experience. (2017) (139)
Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. (1996) (136)
Four-year follow-up of patients undergoing percutaneous balloon mitral commissurotomy. A report from the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry. (1996) (135)
Primary coronary angioplasty for acute myocardial infarction (the Primary Angioplasty Registry). (1994) (134)
Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR) (2018) (134)
A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. (1999) (133)
Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. (2007) (129)
Real‐world use of the Impella 2.5 circulatory support system in complex high‐risk percutaneous coronary intervention: The USpella Registry (2012) (129)
A Practical Approach to Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: An Interventional Perspective. (2016) (124)
Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. (1999) (120)
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators. (1997) (119)
The truth and consequences of the COURAGE trial. (2007) (119)
Pulsed Doppler assessment of left ventricular diastolic filling in coronary artery disease before and immediately after coronary angioplasty. (1987) (117)
Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. (1995) (117)
A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction. (1987) (117)
Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. (1995) (117)
Diagnosis, management, and clinical outcome of cardiac tamponade complicating percutaneous coronary intervention. (2002) (116)
Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality. (2020) (116)
Transcatheter Valve Repair for Patients With Mitral Regurgitation: 30-Day Results of the CLASP Study. (2019) (112)
Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. (2004) (111)
Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. The TAMI Study Groups. (1989) (110)
Predicting LVOT Obstruction After TMVR. (2016) (109)
Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial). (2014) (108)
Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: Do we need more aggressive dosing regimens in unstable angina? (2003) (108)
12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial. (2015) (104)
Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention. (2007) (104)
Effect of Valve Deformity on Results and Mitral Regurgitation After Inoue Balloon Commissurotomy (1992) (100)
Drug-eluting stents: costs versus clinical benefit. (2003) (100)
Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts. (1994) (100)
Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction. (2003) (98)
Cardiac Shock Care Centers: JACC Review Topic of the Week. (2018) (98)
Effect of Cigarette Smoking on Outcome After Thrombolytic Therapy for Myocardial Infarction (1991) (97)
Predictors of long-term survival after percutaneous aortic valvuloplasty: report of the Mansfield Scientific Balloon Aortic Valvuloplasty Registry. (1991) (97)
Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarction. (1986) (96)
Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States (2020) (95)
Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: improved timing, thrombolytic efficacy and ventricular function. (1987) (95)
Simplified scoring system for predicting mortality after percutaneous coronary intervention. (2003) (95)
The transaortic approach for transcatheter aortic valve replacement: initial clinical experience in the United States. (2012) (95)
Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplasty. (1994) (93)
Invasive Hemodynamic Assessment and Classification of In-Hospital Mortality Risk Among Patients With Cardiogenic Shock (2020) (90)
Retrograde percutaneous aortic valve implantation for critical aortic stenosis (2005) (89)
Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. (2004) (89)
Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial). (2011) (89)
Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR). (2007) (88)
A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. (1996) (88)
The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for acute myocardial infarction. (2003) (88)
Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. (1998) (86)
Value of Hemodynamic Monitoring in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support. (2020) (86)
Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction. (2005) (86)
Mechanisms and outcome of severe mitral regulation after inoue balloon valvuloplasty (1993) (85)
Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction (2000) (83)
One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve. (2020) (81)
Relation of hemoglobin A1c to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization. (2003) (81)
Prophylactic versus standby cardiopulmonary support for high risk percutaneous transluminal coronary angioplasty. (1993) (79)
Cost-effectiveness of myocardial perfusion imaging with SPECT in the emergency department evaluation of patients with unexplained chest pain. (1996) (78)
New-onset atrial fibrillation after aortic valve replacement: comparison of transfemoral, transapical, transaortic, and surgical approaches. (2013) (78)
Criteria for successful coronary angioplasty as assessed by alterations in coronary vasodilatory reserve. (1984) (78)
Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial). (2006) (78)
Role of cardiac surgery in the hospital phase management of patients treated with primary angioplasty for acute myocardial infarction. (2000) (77)
Primary coronary angioplasty for acute myocardial infarction complicated by out-of-hospital cardiac arrest. (1995) (76)
Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction. (1989) (76)
Patterns of Coronary Compromise Resulting in Acute Right Ventricular Ischemic Dysfunction (2002) (76)
Myocardial contrast echocardiography is superior to other known modalities for assessing myocardial reperfusion after acute myocardial infarction (2003) (73)
Alcohol Septal Ablation to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Replacement: First-in-Man Study. (2019) (73)
Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience. (1989) (72)
A Cardiac Computed Tomography-Based Score to Categorize Mitral Annular Calcification Severity and Predict Valve Embolization. (2020) (72)
Short‐term results of alcohol septal ablation as a bail‐out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification (2017) (71)
Evaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarction. (2005) (71)
Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device. (2019) (70)
Relation of admission white blood cell count to long-term outcomes after primary coronary angioplasty for acute myocardial infarction (The Stent PAMI Trial). (2003) (70)
Continuous positive airway pressure in the prophylaxis of the adult respiratory distress syndrome. (1976) (69)
Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial). (2004) (68)
Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention. (2004) (68)
Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. (2010) (67)
Outcomes of patients with right ventricular failure requiring short-term hemodynamic support with the Impella RP device. (2018) (66)
Randomized, double-blind, placebo-controlled trial of tissue plasminogen activator in unstable angina. (1989) (65)
Primary angioplasty reduces risk of myocardial rupture compared to thrombolysis for acute myocardial infarction. (1997) (65)
The year in interventional cardiology. (2004) (65)
Rapid hemodynamic improvement after reperfusion during right ventricular infarction. (1995) (64)
Cardiac arrest survival after implementation of automated external defibrillator technology in the in-hospital setting (2009) (64)
Recanalization of Chronically Occluded Aortocoronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion of Urokinase (ROBUST): a serial trial. (1996) (64)
Resolution of refractory no‐reflow with intracoronary epinephrine (2002) (64)
Fibrinolytic therapy: is it a treatment of the past? (2003) (62)
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. (2003) (62)
Initial experience with hyperoxemic reperfusion after primary angioplasty for acute myocardial infarction: results of a pilot study utilizing intracoronary aqueous oxygen therapy. (2002) (61)
Comparison of the prognostic effect of left versus right versus no bundle branch block on presenting electrocardiogram in acute myocardial infarction patients treated with primary angioplasty in the primary angioplasty in myocardial infarction trials. (2005) (61)
Transcatheter caval valve implantation using multimodality imaging: roles of TEE, CT, and 3D printing. (2015) (60)
First in human percutaneous implantation of a balloon expandable transcatheter heart valve in a severely stenosed native mitral valve (2014) (59)
Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: prediction of clinical outcome. (1988) (59)
The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons score in the Placement of Aortic Transcatheter Valves trial. (2014) (58)
Safety of helicopter transport and out-of-hospital intravenous fibrinolytic therapy in patients with evolving myocardial infarction. (1986) (58)
Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study. (2008) (57)
A Prospective, Randomized Evaluation of Prophylactic Intraaortic Balloon Counterpulsation in High Risk Patients With Acute Myocardial Infarction Treated With Primary Angioplasty fn1fn1Funding for this study was provided in part by unrestricted grants from Advanced Cardiovascular Systems, Inc., Santa (1997) (57)
Early Initiation of Impella in Acute Myocardial Infarction Complicated by Cardiogenic Shock Improves Survival: A Meta-Analysis. (2017) (57)
Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. (2003) (57)
Rapid medical relief--Project Medishare and the Haitian earthquake. (2010) (56)
Feasibility study of the use of the TandemHeart® percutaneous ventricular assist device for treatment of cardiogenic shock (2006) (55)
Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. (2005) (55)
Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. (2009) (55)
Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventions. (2006) (54)
An Academic Center's Delivery of Care After the Haitian Earthquake (2010) (54)
Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention. (1999) (54)
Percutaneous coronary interventions in octogenarians. glycoprotein IIb/IIIa receptor inhibitors' safety profile. (2003) (53)
Cardiac biomarkers – the old and the new: a review (2010) (53)
Impact of aortic regurgitation after transcatheter aortic valve implantation: results from the REVIVAL trial. (2012) (53)
Machine Learning Prediction Models for In-Hospital Mortality After Transcatheter Aortic Valve Replacement. (2019) (52)
A new clinical classification for hospital prognosis of unstable angina pectoris. (1995) (52)
The year in interventional cardiology. (2005) (51)
Demonstration of the "no-reflow" phenomenon by digital coronary arteriography. (1986) (51)
Predictors of success for coronary angioplasty performed for acute myocardial infarction. (1988) (51)
Treatment of cardiac risk factors in diabetic patients: How well do we follow the guidelines? (2001) (50)
Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction. (2004) (50)
Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation. (2009) (50)
Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience. (2015) (48)
Percutaneous aortic balloon valvotomy in the United States: a 13-year perspective. (2014) (48)
Impella 2.5 initiated prior to unprotected left main PCI in acute myocardial infarction complicated by cardiogenic shock improves early survival (2017) (47)
Angioplasty therapy of cardiogenic shock: are randomized trials necessary? (1992) (47)
Comparison of Late Luminal Loss Response Pattern After Sirolimus-Eluting Stent Implantation or Conventional Stenting (2004) (47)
The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure. (2017) (47)
Prospective, randomized comparison of 3‐dimensional computed tomography guidance versus TEE data for left atrial appendage occlusion (PRO3DLAAO) (2018) (46)
Emergency coronary artery bypass surgery preserves global and regional left ventricular function after intravenous tissue plasminogen activator therapy for acute myocardial infarction. (1988) (46)
Role of myocardial ischemia during programmed stimulation in survivors of cardiac arrest with coronary artery disease. (1987) (46)
Comparative results of transluminal extraction coronary atherectomy in saphenous vein graft lesions with and without thrombus. (1995) (45)
Emergency percutaneous transluminal coronary angioplasty during acute myocardial infarction for patients more than 70 years of age. (1989) (44)
Cor triatriatum dexter: recognition and percutaneous transluminal correction. (1991) (44)
Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy. (1996) (44)
Frequency of returning to work one and six months following percutaneous coronary intervention for acute myocardial infarction. (2004) (44)
SCAI shock classification in acute myocardial infarction: Insights from the National Cardiogenic Shock Initiative (2020) (44)
Long term survival after early unloading with Impella CP® in acute myocardial infarction complicated by cardiogenic shock (2018) (43)
Favorable Outcomes With Machine Perfusion and Longer Pump Times in Kidney Transplantation: A Single-Center, Observational Study (2010) (43)
Usefulness of the presence of peripheral vascular disease in predicting mortality in acute myocardial infarction patients treated with primary angioplasty (from the Primary Angioplasty in Myocardial Infarction Database). (2005) (42)
Rationale and study design of the CardioGene Study: genomics of in-stent restenosis. (2004) (42)
Mechanical Rotary Atherectomy: The Effects of Microparticle Embolization on Myocardial Blood Flow and Function (1989) (42)
Comparison of coronary stenting versus conventional balloon angioplasty on five-year mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. (2005) (41)
Multivessel balloon angioplasty should be abandoned in diabetic patients! (1998) (41)
Prospective, randomized trial of prolonged intracoronary urokinase infusion for chronic total occlusions in native coronary arteries. (1996) (40)
Relation of number of complex coronary lesions to serum C-reactive protein levels and major adverse cardiovascular events at one year. (2005) (40)
Patterns of coronary compromise leading to bradyarrhythmias and hypotension in inferior myocardial infarction (2005) (40)
Success, safety, and mechanisms of failure of percutaneous coronary intervention for occlusive non-drug-eluting in-stent restenosis versus native artery total occlusion. (2005) (40)
Is direct physician supervision of exercise stress testing routinely necessary? (1997) (39)
1-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study. (2020) (39)
Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction (2012) (39)
An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial. (2015) (39)
The year in interventional cardiology. (2008) (39)
Study design and rationale of the heterotopic implantation of the Edwards‐Sapien XT transcatheter valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER) trial (2016) (38)
Long-term outcomes of percutaneous paravalvular regurgitation closure after transcatheter aortic valve replacement: a multicenter experience. (2015) (38)
Contribution of transesophageal echocardiography to patient diagnosis and treatment: a prospective analysis. (1990) (38)
Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial). (2015) (38)
Prevention of subsequent exercise-induced periinfarct ischemia by emergency coronary angioplasty in acute myocardial infarction: comparison with intracoronary streptokinase. (1986) (37)
Predictors of complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy and the timing of pacemaker implantation. (2007) (37)
PET perfusion and vasodilator function after angioplasty for acute myocardial infarction. (1997) (37)
Transvalvular Ventricular Unloading Before Reperfusion in Acute Myocardial Infarction. (2020) (37)
Predictors of long-term event-free survival after percutaneous balloon mitral valvuloplasty. (1997) (37)
Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction (2003) (36)
Quantitative measurement of coronary flow during medical revascularization (thrombolysis or angioplasty) in patients with acute infarction. (1987) (36)
Costs and outcomes of patients admitted with chest pain and essentially normal electrocardiograms (1998) (36)
Methodologic issues in clinical evaluation of stenosis severity in adults undergoing aortic or mitral balloon valvuloplasty. The NHLBI Balloon Valvuloplasty Registry. (1992) (36)
Balloon mitral valvuloplasty in the United States: a 13-year perspective. (2014) (36)
Effect of Rotablator atherectomy and adjunctive balloon angioplasty on coronary blood flow. (1997) (35)
Evaluating the learning curve in the prospective Randomized Clinical Trial of hemodynamic support with Impella 2.5 versus Intra-Aortic Balloon Pump in patients undergoing high-risk percutaneous coronary intervention: a prespecified subanalysis of the PROTECT II study. (2014) (35)
Mechanisms and outcome of severe mitral regurgitation after Inoue balloon valvuloplasty. North American Inoue Balloon Investigators. (1993) (35)
Complications and Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement With Edwards SAPIEN & SAPIEN XT Valves: A Meta-Analysis of World-Wide Studies and Registries Comparing the Transapical and Transfemoral Accesses. (2015) (35)
Prediction of death and neurologic outcome in the emergency department in out-of-hospital cardiac arrest survivors. (1998) (34)
Impella versus extracorporeal membrane oxygenation for acute myocardial infarction cardiogenic shock. (2020) (34)
Optimizing rotational atherectomy in high‐risk percutaneous coronary interventions: Insights from the PROTECT ΙΙ study (2014) (34)
3D Printing, Computational Modeling, and Artificial Intelligence for Structural Heart Disease. (2020) (34)
Patients with 3-vessel coronary artery disease and impaired ventricular function undergoing PCI with Impella 2.5 hemodynamic support have improved 90-day outcomes compared to intra-aortic balloon pump: a sub-study of the PROTECT II trial. (2015) (33)
Intraoperative angiography to assess graft patency after minimally invasive coronary bypass. (1998) (33)
Repair of a coronary pseudoaneurysm with percutaneous placement of a saphenous vein allograft attached to a biliary stent. (1996) (33)
Application of a cardiac arrest score in patients with sudden death and ST segment elevation for triage to angiography and intervention. (2002) (33)
2-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study. (2021) (32)
Impella support compared to medical treatment for post-cardiac arrest shock after out of hospital cardiac arrest. (2018) (32)
Elective or Emergency Use of Mechanical Circulatory Support Devices During Transcatheter Aortic Valve Replacement. (2016) (32)
Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators. (2000) (32)
Safety and efficacy of urokinase during elective coronary angioplasty. (1991) (32)
Reproducible microvascular dysfunction with dobutamine infusion in Takotsubo cardiomyopathy presenting with ST segment elevation (2006) (32)
Intracoronary fibrin-specific thrombolytic infusion facilitates percutaneous recanalization of chronic total occlusion. (2005) (32)
Do excimer laser angioplasty and rotational atherectomy facilitate balloon angioplasty? Implications for lesion-specific coronary intervention. (1996) (31)
Does proximal location of culprit lesion confer worse prognosis in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction? (2006) (31)
Risk of bleeding after elective percutaneous coronary intervention. (2006) (31)
Exercise testing three days after onset of acute myocardial infarction. (1987) (30)
Early hospital discharge after percutaneous transluminal coronary angioplasty. (1989) (30)
One-year survival in patients with acute myocardial infarction and a saphenous vein graft culprit treated with primary angioplasty. (2003) (30)
Patients with aortic stenosis referred for TAVI: treatment decision, in-hospital outcome and determinants of survival (2011) (30)
Safety and Cost-Effectiveness of Early Discharge After Primary Angioplasty in Low Risk Patients With Acute Myocardial Infarction 11Research funding for this study was provided by unrestricted grants from Advanced Cardiovascular Systems, Santa Clara, California; Mallinckrodt Medical, Inc., Saint Loui (1998) (30)
Racial, Ethnic, and Sex Disparities in Patients With STEMI and Cardiogenic Shock. (2021) (30)
Effect of peripheral cardiopulmonary bypass on left ventricular size, afterload and myocardial function during elective supported coronary angioplasty. (1991) (30)
Percutaneous alcohol septal ablation to acutely reduce left ventricular outflow tract obstruction induced by transcatheter mitral valve replacement (2016) (30)
Acute angiographic analysis of non-ST-segment elevation acute myocardial infarction. (2004) (29)
Transseptal antegrade transcatheter aortic valve replacement for patients with no other access approach—A contemporary experience (2013) (29)
Success, complications, and restenosis following rotational and transluminal extraction atherectomy of ostial stenoses. (1994) (29)
Impact of interventionalist volume, experience, and board certification on coronary angioplasty outcomes in the era of stenting. (2004) (29)
Transcatheter Aortic Valve Replacement: Comparing Transfemoral, Transcarotid, and Transcaval Access. (2018) (29)
Emergent percutaneous cardiopulmonary bypass in patients having cardiovascular collapse in the cardiac catheterization laboratory. (1994) (28)
One-year outcome after therapy with tissue plasminogen activator: report from the Thrombolysis and Angioplasty in Myocardial Infarction trial. (1990) (28)
Suprasternal direct aortic approach transcatheter aortic valve replacement avoids sternotomy and thoracotomy: first-in-man experience†. (2015) (28)
Effects of Impella on Coronary Perfusion in Patients With Critical Coronary Artery Stenosis (2018) (27)
Noninvasive quantification of jeopardized myocardial mass in dogs using 2-dimensional echocardiography and thallium-201 tomography. (1983) (27)
Prospective study of extraction atherectomy in patients with acute myocardial infarction. (1996) (27)
Incidence and predictors of early recurrent ischemia after successful percutaneous transluminal coronary angioplasty for acute myocardial infarction. (1989) (26)
Are residual stenoses after excimer laser angioplasty and coronary atherectomy due to inefficient or small devices? Comparison with balloon angioplasty. (1993) (26)
Prospective Evaluation of Transseptal TMVR for Failed Surgical Bioprostheses: MITRAL Trial Valve-in-Valve Arm 1-Year Outcomes. (2021) (26)
A value-based analysis of hemodynamic support strategies for high-risk heart failure patients undergoing a percutaneous coronary intervention. (2013) (26)
Thrombolysis and angioplasty in acute myocardial infarction. (1988) (26)
Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: results from the primary angioplasty registry. (1995) (26)
Ventricular Septal Defect Complicating ST-Elevation Myocardial Infarctions: A Call for Action. (2017) (25)
Three-Dimensional Printing for Planning of Structural Heart Interventions. (2018) (25)
Prospective Study of TMVR Using Balloon-Expandable Aortic Transcatheter Valves in MAC: MITRAL Trial 1-Year Outcomes. (2021) (25)
Prognostic significance of systolic time intervals after recovery from myocardial infarction. (1981) (25)
A randomized, controlled trial of saphenous vein graft intervention with a filter-based distal embolic protection device: TRAP trial. (2005) (25)
Acute myocardial infarction after manual or automated snow removal. (2001) (25)
Comparison of acute results of prophylactic intraaortic balloon pumping with cardiopulmonary support for percutaneous transluminal coronary angioplasty (PCTA) (1998) (25)
Comparison of left ventricular function and contractile reserve after successful recanalization by thrombolysis versus rescue percutaneous transluminal coronary angioplasty for acute myocardial infarction. (1988) (25)
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. (1996) (25)
One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients. A substudy of the STENT PAMI trial. (2001) (25)
Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy. (2001) (24)
Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS). (2001) (24)
Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction. (2003) (24)
The role of temporary biventricular pacing in the cardiac surgical patient with severely reduced left ventricular systolic function. (2008) (24)
Sudden cardiac death after manual or automated snow removal. (2003) (24)
Comparison of Outcomes of Transcatheter Aortic Valve Replacement Plus Percutaneous Coronary Intervention Versus Transcatheter Aortic Valve Replacement Alone in the United States. (2016) (24)
A case against low-volume percutaneous coronary intervention centers. (2009) (24)
Combination of lovastatin, enalapril, and colchicine does not prevent restenosis after percutaneous transluminal coronary angioplasty. (1995) (24)
Usefulness of embolic protection devices during saphenous vein graft intervention in a nonselected population. (2005) (23)
Mechanical rotational atherectomy. (1992) (23)
Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: A 10‐years us perspective (2015) (23)
Relation of periprocedural bleeding complications and long-term outcome in patients undergoing percutaneous coronary revascularization (from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial). (2009) (22)
Immediate and long-term results of elective and emergent percutaneous interventions on protected and unprotected severely narrowed left main coronary arteries. (1999) (22)
Favorable early and long-term prognosis following coronary bypass surgery therapy for myocardial infarction: results of a multicenter trial. TAMI Study Group. (1989) (22)
Impact of mechanical reperfusion on clinical outcome in elderly patients with right ventricular infarction (2006) (22)
Hyperoxemic perfusion of the left anterior descending coronary artery after primary angioplasty in anterior ST‐elevation myocardial infarction (2006) (22)
Intramural drug delivery by direct injection within the arterial wall: first clinical experience with a novel intracoronary delivery-infiltrator system. (1997) (22)
High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction. (2015) (22)
Death with dipyridamole-thallium imaging. (1988) (21)
Transcatheter Mitral Valve Repair With MitraClip for Symptomatic Functional Mitral Valve Regurgitation. (2017) (21)
Coronary flow reserve measured during cardiac catheterization. (1984) (21)
Two-year clinical follow-up of 90Sr/90 Y β-radiation versus placebo control for the treatment of in-stent restenosis (2005) (21)
Emergent use of retrograde left ventricular support in patients after transcatheter aortic valve replacement (2013) (21)
Glidewire treatment of resistant coronary occlusions. (1993) (20)
Effects of endovascular cooling on infarct size in ST‐segment elevation myocardial infarction: A patient‐level pooled analysis from randomized trials (2018) (20)
Effect of reperfusion modality on outcome in nonsmokers and smokers with acute myocardial infarction (a Primary Angioplasty in Myocardial Infarction [PAMI] substudy). PAMI Investigators. (1996) (20)
Right ventricular performance at rest and during stress with chronic proximal occlusion of the right coronary artery. (2003) (20)
901-1 A Prospective, Randomized Trial Evaluating Early Discharge (Day 3) without Non-invasive Risk Stratification in Low Risk Patients with Acute Myocardial Infarction: PAMI-2 (1995) (20)
Primary coronary angioplasty versus thrombolysis. (1997) (19)
The use of vascular closure devices and impact on major bleeding and net adverse clinical events (NACEs) in balloon aortic valvuloplasty: A sub‐analysis of the BRAVO study (2014) (19)
Long‐term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement (2015) (19)
Microvascular obstruction and myocardial function after acute myocardial infarction: assessment by using contrast-enhanced cine MR imaging. (2006) (19)
Usefulness of creatinine clearance in predicting early and late death after primary angioplasty for acute myocardial infarction. (2003) (19)
Effects of reperfusion on complete heart block complicating anterior myocardial infarction. (1984) (19)
Evaluation of thrombus removal by transluminal extraction coronary atherectomy by percutaneous coronary angioscopy. (1994) (19)
Reducing radiation dose in the cardiac catheterization laboratory by design alterations and staff education. (2002) (19)
Operator and institutional volume do not affect the procedural outcome of primary angioplasty therapy (1996) (19)
Impella support and acute kidney injury during high‐risk percutaneous coronary intervention: The Global cVAD Renal Protection Study (2020) (19)
Detailed clinical and angiographic analysis of transluminal extraction coronary atherectomy for complex lesions in native coronary arteries. (1995) (19)
Optimal burr and adjunctive balloon sizing reduces the need for target artery revascularization after coronary mechanical rotational atherectomy. (1996) (19)
Validation of a predictive risk score for radiocontrast-induced nephropathy following percutaneous coronary intervention. (2007) (19)
Reperfusion therapy of acute myocardial infarction. (1988) (19)
Occlusion of a saphenous vein graft aneurysm with a vein-covered stent. (2002) (18)
Vascular endothelial growth factor-165 gene therapy promotes cardiomyogenesis in reperfused myocardial infarction. (2008) (18)
Validation of a decision support tool for the evaluation of cardiac arrest victims (1998) (18)
Percutaneous extraction of fractured guidewire from distal right coronary artery. (1991) (18)
Prospective Evaluation of TMVR for Failed Surgical Annuloplasty Rings: MITRAL Trial Valve-in-Ring Arm 1-Year Outcomes. (2021) (18)
Coronary angioplasty as therapy for acute myocardial infarction: University of Michigan experience. (1987) (18)
Intracoronary fibrinolytic therapy in acute myocardial infarction: Preliminary report of a randomized trial (1982) (18)
Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: Management of paravalvular regurgitation after TAVR (2013) (18)
Intentional Right Atrial Exit and Carbon Dioxide Insufflation to Facilitate Subxiphoid Needle Entry Into the Empty Pericardial Space: First Human Experience. (2015) (18)
Complications of percutaneous aortic valve replacement : experience with the Cribier-Edwards™ percutaneous heart valve (2006) (18)
Outcomes of hemodynamic support with Impella in very high-risk patients undergoing balloon aortic valvuloplasty: Results from the Global cVAD Registry. (2017) (18)
Thrombotic valvular dysfunction with transcatheter mitral interventions for postsurgical failures (2017) (18)
Hemodynamic support with impella 2.5 during balloon aortic valvuloplasty in a high-risk patient. (2011) (17)
Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients. (2022) (17)
The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry. (2017) (17)
Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. (2007) (17)
Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter U.S. Registry. (2018) (17)
Multi- Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock. (2020) (17)
Feasibility of Early Mechanical Support During Mechanical Reperfusion of Acute Myocardial Infarct Cardiogenic Shock. (2017) (17)
Rates of vascular access use in transcatheter aortic valve replacement: A look into the next generation (2015) (17)
Percutaneous triple-valve balloon valvuloplasty in a pregnant woman. (1991) (17)
Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial). (2008) (17)
Usefulness of adjunctive angioscopy and extraction atherectomy before stent implantation in high-risk aortocoronary saphenous vein grafts. (1995) (16)
Comparison of effectiveness of primary angioplasty for proximal versus distal right coronary artery culprit lesion during acute myocardial infarction. (2002) (16)
The long-term consequences of lost intracoronary stents. (2002) (16)
Rescue angioplasty: does the concept need to be rescued? (2004) (16)
Direct angioplasty for acute myocardial infarction (1995) (16)
Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients? (2009) (15)
Temporal Trends in Utilization of Right-Sided Heart Catheterization Among Percutaneous Ventricular Assist Device Recipients in Acute Myocardial Infarction Complicated by Cardiogenic Shock. (2018) (15)
Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation: TRISCEND Study 30-Day Results. (2022) (15)
Suboptimal inhibition of platelet aggregation following tirofiban bolus in patients undergoing percutaneous coronary intervention for unstable angina pectoris. (2003) (15)
Reversibility of coronary collaterals and alteration in regional coronary flow reserve after successful angioplasty. (1984) (15)
2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention (2008) (15)
Role of CT imaging in left atrial appendage occlusion for the WATCHMAN™ device. (2020) (15)
Emergent use of Impella CP™ during transcatheter aortic valve replacement: Transaortic access (2015) (15)
One-year results of percutaneous myocardial revascularization for refractory angina pectoris. (2003) (15)
The Role of Impella for Hemodynamic Support in Patients With Aortic Stenosis (2018) (15)
Respect the Septal Perforator: Septal Artery Perforation During CTO PCI Resulting in Massive Interventricular Septal Hematoma and Biventricular Cardiac Obstructive Shock. (2017) (14)
Percutaneous atrial septostomy for urgent palliative treatment of severe refractory cardiogenic shock due to right ventricular infarction (2003) (14)
Beyond TIMI III flow. (2000) (14)
Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study). (2009) (14)
Transcaval retrograde transcatheter aortic valve replacement for patients with no other access: first-in-man experience with CoreValve. (2014) (14)
Percutaneous Right Ventricular Assist Device Support in a Patient Supported by an LVAD. (2016) (14)
Assessment of a novel software tool in the selection of aortic valve prosthesis size for transcatheter aortic valve replacement. (2014) (14)
One-year outcomes from the TAXUS express stent versus cypher stent. (2009) (14)
Assessment of potentially salvageable myocardium during acute myocardial infarction: use of postextrasystolic potentiation. (1984) (14)
Mechanical circulatory support with impella to facilitate percutaneous coronary intervention for post‐TAVI bilateral coronary obstruction (2016) (14)
Transcaval access for TAVR across a polyester aortic graft (2015) (13)
Planning transcaval access using CT for large transcatheter implants. (2014) (13)
Multicenter registry of coronary atherectomy using the transluminal extraction-endarterectomy catheter (1990) (13)
TCT-8 Updated 30-Day Outcomes for the U.S. Early Feasibility Study of the SAPIEN M3 Transcatheter Mitral Valve Replacement System (2019) (13)
Surgery or stent? The gap continues to narrow (2002) (13)
Electrocardiographic responses to deer hunting activities in men with and without coronary artery disease. (2007) (13)
Avoiding hemodynamic collapse during high‐risk percutaneous coronary intervention: Advanced hemodynamics of impella support (2017) (13)
The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients. (2022) (12)
Intentional right atrial exit for microcatheter infusion of pericardial carbon dioxide or iodinated contrast to facilitate sub‐xiphoid access (2015) (12)
Comparison of the use of hemodynamic support in patients ≥80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study). (2014) (12)
Association of peripheral artery disease with in‐hospital outcomes after endovascular transcatheter aortic valve replacement (2019) (12)
Treatment of uncrossable chronic total coronary occlusions with the frontrunner: multicenter experience (2002) (12)
The duke multicenter coronary transluminal extraction-endarterectomy registry: Acute and chronic results (1991) (12)
Prolonged urokinase infusion for chronic total native coronary occlusions: clinical, angiographic, and treatment observations. (1995) (12)
The role of atherectomy in the management of saphenous vein grafts disease (1991) (12)
Frequency of 30‐day readmission and its causes after percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock (2019) (12)
Lack of relationship between the time to reperfusion and short-term mortality after primary infarct angioplasty (1998) (12)
Transcaval access for the emergency delivery of 5.0 liters per minute mechanical circulatory support in cardiogenic shock (2020) (12)
Rotational ablation using the rotablator for angiographically unfavorable lesions (1991) (11)
Hemodynamic support using the Impella 2.5 catheter system during high-risk percutaneous coronary intervention in a patient with severe aortic stenosis. (2010) (11)
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock. (2020) (11)
Primary percutaneous interventions for acute myocardial infarction in octogenarians: A single‐center experience (2002) (11)
715-2 A Prospective, Randomized Trial Evaluating the Prophylactic Use of Balloon Pumping in High Risk Myocardial Infarction Patients: PAMI-2 (1995) (11)
Primary percutaneous coronary angioplasty: a protagonist's view. (1988) (11)
A comparative analysis of primary stenting and optimal balloon coronary angioplasty in acute myocardial infarction. Six month results from the STENT PAMI trial. (2000) (11)
Procedural cost of new interventional devices. (1994) (11)
Transcatheter tricuspid valve intervention: the next frontier. (2015) (11)
Restenosis after successful mechanical rotary atherectomy with the auth rotablator (1990) (11)
Improved Outcomes in Patients with Severely Depressed LVEF Undergoing Percutaneous Coronary Intervention with Contemporary Practices: Impella-Supported High-Risk Percutaneous Coronary Intervention in Patients with Severely Depressed LVEF. (2022) (11)
Influence of isoprostane F2α-III on reflow after myocardial infarction (2003) (11)
Multimodality Imaging of the Tricuspid Valve for Assessment and Guidance of Transcatheter Repair. (2018) (11)
Coronary rotational atherectomy: clinical application. (1991) (11)
Hemodynamic and metabolic effects of venoarterial cardiopulmonary support in coronary artery disease. (1991) (11)
Vasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock (2021) (11)
Clinical, hemodynamic, electrocardiographic and mechanical events during nonocclusive, coronary atherectomy and comparison with balloon angioplasty. (1992) (11)
Predictors of maintained infarct artery patency after primary angioplasty in high risk patients in PAMI-2 (1996) (11)
Outcome of ventricular fibrillation developing during percutaneous coronary interventions in 19,497 patients without cardiogenic shock. (2005) (11)
Successful resuscitation of a patient with critical aortic stenosis and cardiac arrest by peripheral cardiopulmonary support system. (1990) (10)
Radiographic Detection of Single Strut Leg Separations as a Putative Basis for Prophylactic Explantation of Björk-Shiley Convexo-Concave Heart Valves (1996) (10)
Conditioned blood reperfusion during angioplasty (CoBRA) treatment of acute myocardial infarction (2001) (10)
Usefulness of percutaneous transluminal coronary angioplasty after new device coronary interventions. (1994) (10)
Angioscopic plaque friability: A new risk factor for procedural complications following sephenous vein graft interventions (1996) (10)
Balloon expandable transcatheter heart valves for native mitral valve disease with severe mitral annular calcification. (2016) (10)
Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial. (2015) (10)
Sex‐related difference in the use of percutaneous left ventricular assist device in patients undergoing complex high‐risk percutaneous coronary intervention: Insight from the cVAD registry (2019) (10)
Computed Tomography-Derived 3D Modeling to Guide Sizing and Planning of Transcatheter Mitral Valve Interventions. (2021) (10)
Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. (2007) (10)
Radionuclide evaluation of postextrasystolic potentiation of left ventricular function induced by atrial and ventricular stimulation. (1982) (10)
Value of exercise radionuclide ventriculography and thallium-201 scintigraphy in evaluating successful coronary angioplasty: comparison with coronary flow reserve, translesional gradient and percent diameter stenosis. (1987) (10)
The chronic coronary flow reserve provided by saphenous vein bypass grafts as determined by digital coronary radiography. (1984) (10)
"Watchful waiting" after thrombolysis: it's time for a re-evaluation. (2003) (10)
Submaximal exercise thallium-201 SPECT for assessment of interventional therapy in patients with acute myocardial infarction. (1991) (9)
Early reperfusion therapy improves left ventricular function after acute inferior myocardial infarction associated with right coronary artery disease. (1987) (9)
Safety and effectiveness of MANTA vascular closure device after large-bore mechanical circulatory support: Real-world experience. (2020) (9)
Colombian experience with transcatheter aortic valve implantation of medtronic CoreValve. (2012) (9)
Comparison of Outcomes of Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Cardiomyopathy in Patients ≤65 Years Versus >65 Years. (2020) (9)
Progress in clinical trials (2004) (9)
Percutaneous Rescue of an Embolized Valve After Transcatheter Mitral Valve Replacement. (2017) (9)
Update on Cardioprotective Strategies for STEMI (2021) (9)
Improved targeting of radio-frequency ablation probes and thermal sensors: a preliminary investigation of flat-panel CT-guided ablation of renal tumors performed in the cardiac catheterization laboratory. (2011) (9)
Rapid bedside coronary angiography with a portable fluoroscopic imaging system. (1997) (9)
Left ventricular remodeling and systolic deterioration in acute myocardial infarction: findings from the Stent-PAMI Study. (2005) (8)
Clinical outcome of patients evaluated with emergency centre myocardial perfusion SPET for unexplained chest pain (1996) (8)
A time-to-treatment analysis in the medicine versus angiography in thrombolytic exclusion (MATE) trial. (2001) (8)
Further validation of the hybrid algorithm for CTO PCI; difficult lesions, same success. (2017) (8)
Aspiration Thrombectomy in Patients Undergoing Primary Angioplasty for ST Elevation Myocardial Infarction: An Updated Meta-Analysis. (2015) (8)
Improved Short-Term Outcomes of Primary Coronary Stenting Compared to Primary Balloon Angioplasty in Acute Myocardial Infarction at Experienced Centers: The PAMI Study Group Experience (1999) (8)
Use of tissue plasminogen (1987) (8)
Role of percutaneous transluminal coronary angioplasty in acute myocardial infarction. (1987) (8)
Angioscopic guided interventions in a saphenous vein bypass graft. (1994) (8)
Lithotripsy-Facilitated Mitral Balloon Valvuloplasty for Senile Degenerative Mitral Valve Stenosis. (2019) (8)
A prospective, randomized placebo-controlled multicenter trial evaluating fenoldopam mesylate for the prevention of contrast induced nephropathy: The CONTRAST trial (2003) (8)
Predictors of acute and long-term outcome with transluminal extraction atherectomy: the New Approaches to Coronary Intervention (NACI) registry. (1997) (8)
Caval Valve Implantation for Tricuspid Regurgitation: Insights From the United States Caval Valve Registry. (2020) (8)
Additive Value of Preprocedural Computed Tomography Planning Versus Stand‐Alone Transesophageal Echocardiogram Guidance to Left Atrial Appendage Occlusion: Comparison of Real‐World Practice (2021) (8)
Influence of isoprostane F2alpha-III on reflow after myocardial infarction. (2004) (8)
Acute occlusion of a left internal mammary artery graft immediately after redo coronary artery bypass surgery: successful rescue PTCA. (1997) (8)
Comparison of Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients ≥80 Years of Age. (2019) (8)
Time course analysis of gene expression identifies multiple genes with differential expression in patients with in-stent restenosis (2011) (7)
The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized Trial. (2019) (7)
Percutaneous Repair of Mitral Valve Leaflet Perforation. (2019) (7)
Variation in hospital length of stay in patients with acute myocardial infarction undergoing primary angioplasty and the need to change the diagnostic-related group system. (2003) (7)
Effectiveness of primary angioplasty for acute myocardial infarction in patients on dialysis. (2004) (7)
Temporal trends of survival and utilization of mechanical circulatory support devices in patients with in‐hospital cardiac arrest secondary to ventricular tachycardia/ventricular fibrillation (2019) (7)
Design and Objectives of the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events (EXCITE) Study (1999) (7)
Transfemoral Aortic Valve Replacement in Failing Aortic Root Homografts (2014) (7)
Recanalization of chronic total coronary occlusions using a laser guide wire: The Eu and US total experience (1996) (7)
ACUTE MYOCARDIAL INFARCTION AFTER MANUAL OR AUTOMATED SNOW REMOVAL (2000) (7)
1022-103 Does Primary Angioplasty Improve the Prognosis of Patients with Diabetes and Acute Myocardial Infarction? (1995) (7)
Influence of regional cardiovascular mortality on the use of angiography after acute myocardial infarction. (1997) (7)
Primary angioplasty for myocardial infarction improves long-term survival: PAMI-1 follow-up (1996) (7)
Outcomes Among Patients Transferred for Revascularization With Impella for Acute Myocardial Infarction With Cardiogenic Shock from the cVAD Registry. (2019) (7)
Normalization of coronary flow reserve immediately after stenting but not after PTCA (1996) (7)
Mechanical circulatory support for patients with cardiogenic shock. (2019) (7)
Increased Risk of Perioperative Ischemic Stroke in Patients Who Undergo Noncardiac Surgery with Preexisting Atrial Septal Defect or Patent Foramen Ovale. (2020) (7)
Acute contrast nephropathy after coronary intervention: Incidence, risk factors, and relationship to mortality (1996) (7)
Complete percutaneous apical access and closure: Short and intermediate term outcomes (2020) (6)
Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization (2019) (6)
Percutaneous left ventricular assist device in acute myocardial infarction and cardiogenic shock. (2005) (6)
Maintenance of valvular integrity with Impella left heart support: Results from the multicenter PROTECT II randomized study (2018) (6)
The Role of Mechanical Circulatory Support During Percutaneous Coronary Intervention in Patients Without Severely Depressed Left Ventricular Function. (2017) (6)
Randomized Evaluation of Vessel Preparation With Orbital Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Artery Lesions: Design and Rationale of the ECLIPSE Trial. (2022) (6)
Door-to-unload: left ventricular unloading before reperfusion in ST-elevation myocardial infarction. (2021) (6)
Central Venous Pressure and Clinical Outcomes During Left-Sided Mechanical Support for Acute Myocardial Infarction and Cardiogenic Shock (2020) (6)
Mechanical circulatory support following out-of-hospital cardiac arrest: Insights from the National Cardiogenic Shock Initiative. (2020) (6)
Contemporary percutaneous treatment of infrapopliteal arterial disease: a practical approach. (2007) (6)
Angiographic risk factors for coronary restenosis following mechanical rotational atherectomy (1991) (6)
Retrograde percutaneous closure of a ventricular septal defect after myectomy for hypertrophic obstructive cardiomyopathy. (2013) (6)
Hemodynamic and metabolic effects of cardiopulmonary support during PTCA (1990) (6)
Cardiac resuscitation using emergency aortic balloon valvuloplasty. (1989) (6)
Improvement in left ventricular function following higher‐risk percutaneous coronary intervention in patients with ischemic cardiomyopathy (2020) (6)
Safety of percutaneous transfemoral coronary and peripheral procedures via aortofemoral synthetic vascular grafts. (2005) (6)
Feasibility study of percutaneous transluminal myocardial revascularization (PTMR) with a Holmium laser and fiberoptic delivery system (1998) (6)
Prophylactic intraaortic balloon pumping for acute myocardial infarction does not improve left ventricular function (1996) (5)
Interventional Imaging for Structural Heart Disease: Challenges and New Frontiers of an Emerging Multi-disciplinary Field (2019) (5)
Coronary perforation: An unreported complication after intracoronary stent implantation (1996) (5)
COST-EFFECTIVENESS AND QUALITY OF LIFE IMPROVEMENTS: IMPELLA HEMODYNAMIC SUPPORT COMPARED WITH INTRA- AORTIC BALLOON PUMP IN HIGH RISK PATIENTS RECEIVING PCI (2012) (5)
Impact of different reperfusion modalities on ventricular function after acute myocardial infarction. (1988) (5)
Impact of CMS coverage decision on access to transcatheter aortic valve replacement (2013) (5)
Use of tissue plasminogen activator in the emergency department for acute myocardial infarction. (1987) (5)
Socioeconomic Disparities in Access for Watchman Device Insertion in Patients with Atrial Fibrillation and at Elevated Risk of Bleeding (2019) (5)
TCT-375 Optimizing Rotational Atherectomy in High-Risk Percutaneous Coronary Interventions. Insights from the PROTECT II study (2012) (5)
Sex-Based Differences in Outcomes With Percutaneous Transcatheter Repair of Mitral Regurgitation With the MitraClip System: Transcatheter Valve Therapy Registry From 2011 to 2017. (2021) (5)
Safety of AngioJet thrombectomy in acute ST-segment elevation myocardial infarction: a large, single-center experience. (2006) (5)
Percutaneous mechanical thrombectomy of left atrial appendage thrombus with bilateral neuro-embolic protection followed by closure of left atrial appendage. (2012) (5)
Relationship between myocardial perfusion and function following coronary reflow in the canine heart using single photon emission computed tomography and two-dimensional echocardiography. (1985) (5)
Identification of ultra low-risk patients following primary angioplasty for acute myocardial infarction (1996) (5)
TRANSCATHETER AORTIC VALVE REPLACEMENT VERSUS SURGICAL AORTIC VALVE REPLACEMENT IN A LOW TO INTERMEDIATE RISK POPULATION (2014) (5)
Total aorto‐ostial chronic occlusion of the right coronary artery successfully recanalized via retrograde approach (2011) (5)
Value of transesophageal echocardiography during complex or high-risk coronary interventions in the cardiac catheterization laboratory. (1991) (5)
Determinants of Hospital Charges and Costs in Acute Myocardial Infarction: A Report from the Myocardial Infarction Cost Study (MICS) Group (1996) (5)
782-6 Clinical and Angiographic Followup to a Prospective Study of Transluminal Extraction Atherectomy in High Risk Patients with Acute Myocardial Infarction (1995) (5)
TCT-318 Hemodynamics of High-Risk Percutaneous Coronary Intervention With and Without Mechanical Circulatory Support: A Pilot Study With Pressure Volume Loop Analysis (2019) (5)
Interventional therapy of the acute coronary syndromes. (2002) (5)
TCT-714 Transcatheter mitral valve replacement with balloon expandable valves in native mitral valve disease due to severe mitral annular calcification: Results from the first global registry (2015) (5)
Rotational Atherectomy of Three Overlapping Stent Layers. (2016) (4)
Mitral Annuloplasty Ring Fracture and Annular Injury During Transcatheter Mitral Valve-in-Ring Intervention. (2017) (4)
Renal Function–Based Contrast Threshold Predicts Kidney Injury in Transcatheter Aortic Valve Replacement (2022) (4)
Clinical outcomes with on‐label and off‐label use of the transcatheter heart valve in the United States (2014) (4)
Impella mechanical circulatory support for Takotsubo syndrome with shock: A retrospective multicenter analysis. (2021) (4)
Mechanical Circulatory Support in Cardiogenic Shock due to Structural Heart Disease. (2021) (4)
Percutaneous intervention of unprotected left main coronary artery. (2003) (4)
Early use of coronary angiography and intervention. (1999) (4)
Left atrial appendage closure with amplatzer septal occluder in patients with atrial fibrillation: CT-based morphologic considerations. (2015) (4)
The Role of Invasive Therapy of Acute Myocardial Infarction after TIMI II‐B (1989) (4)
Reply: The Role of 3D Printing in Structural Heart Disease: All That Glitters Is Not Gold. (2015) (4)
Vacuuming the LAA: Left Atrial Appendage Thrombectomy Using AngioVac to Facilitate Percutaneous Mitral Balloon Valvuloplasty (2020) (4)
Hemodynamic Effects of Left-Atrial Venous Arterial Extra-Corporeal Membrane Oxygenation (LAVA-ECMO) (2021) (4)
Real world outcomes using 20 mm balloon expandable SAPIEN 3/ultra valves compared to larger valves (23, 26, and 29 mm)–a propensity matched analysis (2021) (4)
Percutaneous atherectomy catheters. (1988) (4)
The first generation of angioplasty. (2009) (4)
IMPELLA IMPROVES CLINICAL OUTCOMES WHEN EXTENSIVE REVASCULARIZATION IS PERFORMED: THE PROTECT II STUDY (2012) (4)
Reviving Invasive Hemodynamic Monitoring in Cardiogenic Shock. Invasive Hemodynamic Monitoring in Cardiogenic Shock. (2021) (4)
Incidence and Predictors of Angiographic Restenosis and Reocclusion After Primary Infarct Stenting - Core lab Analysis From the PAMI Stent Pilot Study (1998) (4)
Watchman in ascending aorta for systemic protection (WAASP): Novel use of Watchman in ascending aorta for embolic protection—first in man (2018) (4)
Efficacy of angioscopy in determining the effectiveness of intracoronary urokinase and TEC atherectomy thrombus removal from an occluded saphenous vein graft prior to stent implantation. (1995) (4)
Clinical predictors of in-hospital death in patients with cardiogenic shock selected to undergo early revascularization (2002) (4)
Drug-eluting stents: costs vs. clinical benefit ☆ (2003) (4)
Patent foramen ovale closure with vena cava thrombus: You need an arm and a neck! (2020) (4)
TCT-626 Validating a prediction modeling tool for LVOT obstruction after transcatheter mitral valve replacement. (2016) (4)
TCT-24 Global cVAD Registry: A global initiative in percutaneous circulatory support From the cVAD Steering Committee on behalf of all cVAD Investigators. (2016) (3)
Left ventricular end‐diastolic pressure in acute myocardial infarction: A loaded target in need of unloading (2019) (3)
Very Late (10-Year-Old) Bare Metal Stent Thrombosis (2009) (3)
919-11 Plaque Pulverization During Rotablator Atherectomy: Does It Impair Coronary Flow Dynamics? (1995) (3)
Impaired Culprit Vessel Flow in Acute Coronary Syndromes Ineligible for Thrombolysis (2000) (3)
Successful MitraClip XTR for Torrential Mitral Regurgitation Secondary to Papillary Muscle Rupture as a Complication of Acute Myocardial Infarction (2019) (3)
Transcaval Access for Large Bore Devices (2019) (3)
Primary angioplasty. (1995) (3)
Transseptal approach for the management of paravalvular regurgitation after transcatheter aortic valve replacement (2013) (3)
Neuro‐embolic protection during percutaneous balloon mitral valvuloplasty (2007) (3)
Left Atrial Venoarterial Extracorporeal Membrane Oxygenation for Acute Aortic Regurgitation and Cardiogenic Shock (2022) (3)
Coronary thrombosis during acute myocardial infarction: Roberts was right! (1998) (3)
Impella RP Post Approval Study: First Multi-Center, Prospective Post Market Approval Results for the Impella RP in Patients with Right Ventricular Failure (2017) (3)
Exercise-induced nonsustained ventricular tachycardia: a significant marker of coronary artery disease? (2002) (3)
TCT-405 SYMPLICITY HTN-3: Outcomes in the African-American and non-African American Populations (2014) (3)
COST-EFFECTIVENESS OF IMPELLA HEMODYNAMIC SUPPORT IN THE EMERGENT CARE PATIENT GROUP (2012) (3)
Efficacious and safe transluminal extraction atherectomy in patients with unfavorable coronary lesions (1991) (3)
Bifurcation Stenting: Unnecessary Challenge or a Last Frontier in Intervention (2006) (3)
Vacuum to the Rescue: Aspiration of a Large Mobile Aortic Arch Thrombus With the AngioVac System Utilizing Transcaval Access. (2021) (3)
Abstract 3794: Systemic Hypothermia to Prevent Contrast Nephropathy: the COOL RCN Pilot Trial (2006) (3)
Optimal Burr and adjunctive balloon sizing alters the need for target vessel revascularization after rotablator atherectomy (1996) (3)
Multiple lesion coronary intervention is associated with higher mortality in primary angioplasty for acute myocardial infarction: The stent PAMI trial (2003) (3)
Balloon Aortic and Pulmonic Valvuloplasty (2005) (3)
Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention (2021) (3)
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. (2005) (3)
1022-82 A prospective, randomized trial of mild hypothermia during primary percutaneous intervention for acute myocardial infarction (COOL-MI): One-year clinical outcome (2004) (3)
Alternative Access for Mechanical Circulatory Support (2020) (3)
TCT-244 The Impella to Balloon (ITB) Strategy Limits Infarct Size and Improves Survival in Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Bench to Bedside Study (2015) (3)
Mechanical Circulatory Support in Myocardial Infarction Complicated by Cardiogenic Shock: Impact of Sex and Timing (2022) (3)
Using the Arm for Structural Interventions: Case Selection or Wave of the Future. (2020) (3)
High-Risk Chronic Total Occlusion Percutaneous Coronary Interventions Assisted With TandemHeart. (2019) (3)
Optimal TR-band weaning strategy while minimizing vascular access site complications. (2018) (3)
TEC in acute ischemic syndromes. (1995) (2)
Comparison of a new bioprosthetic mitral valve to other commercially available devices under controlled conditions in a porcine model (2021) (2)
Transcatheter Edge-to-Edge Repair in Patients With Anatomically Complex Degenerative Mitral Regurgitation. (2023) (2)
Intracoronary streptokinase for myocardial infarction. (1983) (2)
Guidewire Facilitation of Internal Mammary Artery Cannulation (1990) (2)
Clinical Features and Outcomes in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction: Early versus Recent Experience with Impella. (2021) (2)
Alternative Access for Transcatheter Aortic Valve Replacement: A Comprehensive Review. (2021) (2)
TCT-121 Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Insights from the cVAD Registry. (2016) (2)
Tricuspid Valve Intervention: New Direction and New Hope. (2016) (2)
Local intramural delivery of 60% ethyl alcohol for treatment of recalcitrant in‐stent restenosis (2004) (2)
Ischemia-driven target vessel revascularization after-primary percutaneous coronary intervention: patients at risk and their outcomes. (2005) (2)
Multifocal plaque instability correlates with elevated C-reactive protein (2002) (2)
Inter-assay variability in the degree of platelet inhibition following GPIIb/IIIa receptor blockade in patients undergoing coronary intervention: a comparison of three different point-of-care assays (2002) (2)
Comparison of Deep Sedation and General Anesthesia With an Endotracheal Tube for Transcaval Transcatheter Aortic Valve Replacement: A Pioneering Institution's Experience. (2021) (2)
Medical Device Evaluation: You Can Be Rich or Famous But Not Both! (2000) (2)
Streptokinase angioplasty myocardial infarction trial: Early and late results (1991) (2)
Percutaneous Approaches to the Treatment of Mitral Leaflet Perforation and to Residual Regurgitation After Transcatheter Edge-to-Edge Mitral Valve Repair. (2019) (2)
Immediate effect of percutaneous myocardial laser revascularization on hemodynamics and left ventricular systolic function in severe angina pectoris. (2001) (2)
Angiographic outcomes after arterial recanalization of refractory occlusions with the PRIMA™ excimer laser wire (1996) (2)
Cerebral protection against left ventricular thrombus during transcatheter aortic valve replacement in a patient with critical aortic stenosis. (2013) (2)
TCT-813 Culprit-Vessel Versus Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: Insights From the National Cardiogenic Shock Initiative (2019) (2)
What is high-risk PCI, and how do you safely perform it? (2011) (2)
TCT-91 1-Year Outcomes From the Multicenter, Prospective Study With the Novel PASCAL Transcatheter Valve Repair System for Patients With Mitral Regurgitation in the CLASP Study (2019) (2)
Modified Transcaval Left Atrial Venoarterial Extracorporeal Membrane Oxygenation Without Preplanning Contrast CT: Step-by-Step Guide. (2022) (2)
FEASIBILITY OF TRANSCAVAL ACCESS FOR THE DELIVERY OF MECHANICAL CIRCULATORY SUPPORT IN CARDIOGENIC SHOCK (2018) (2)
Transcatheter Aortic Valve Replacement with a Retro-Annular Circumflex Artery (2020) (2)
Regional Variation in Procedural and Clinical Outcomes Among Patients With ST Elevation Myocardial Infarction With Cardiogenic Shock. (2020) (2)
The Changing Landscape of Cardiogenic Shock: One Step Closer to Speaking a Common Tongue (2022) (2)
HEMODYNAMIC SUPPORT WITH IMPELLA 2.5 IN HIGH-RISK INTERVENTIONS FOR PATIENTS WITH AORTIC STENOSIS (2011) (2)
COMPARISON OF BLEEDING DEFINITIONS, BARC, GUSTO, TIMI AND VARC IN PATIENTS UNDERGOING BALLOON AORTIC VALVULOPLASTY: RESULTS FROM A TWO-CENTER REGISTRY (2012) (2)
Seminar on balloon aortic valvuloplasty-I (1991) (2)
Transcatheter vacuum‐assisted left‐sided mass extraction with the AngioVac system (2022) (2)
Transesophageal Echocardiography: Current Indications (1989) (2)
Hemodynamic support in high-risk percutaneous coronary interventions and cardiogenic shock (2012) (2)
First-in-man late partial recanalisation after LARIAT suturing of the left atrial appendage successfully treated with an AMPLATZERª septal occluder device. (2015) (2)
Abstract 23079: Clinical Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Mitral Valve-in-Valve) and Surgical Rings (Mitral Valve-in-Ring) in the United States: Data From the STS/ACC/TVT Registry (2017) (2)
Health Services and Outcomes Research Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Standard Care Among Inoperable Patients With Severe Aortic Stenosis (2012) (2)
IT FITS! (Intelligence Transfer: From Images to Solutions) Stenting of an Ostial Left Internal Thoracic Artery Stenosis (1999) (2)
Abstract 15943: Phenotypes of Cardiogenic Shock Associated With Increasing In-Hospital Mortality: A Report From The National Cardiogenic Shock Working Group Registry (2019) (2)
TCT-888 Patients With Aortic Stenosis Referred For Transcatheter Aortic Valve Implantation: Treatment Decision, In-hospital Outcome And Determinants Of Survival (2012) (2)
Letter by O'Neill and Ohman Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis". (2019) (2)
Coronary rotablation and reserve: can they occur together? (1995) (2)
Rescue angioplasty—the MERLIN trial: Reply (2005) (2)
3 YEAR OUTCOMES OF TRANSCATHETER MITRAL VALVE-IN-VALVE, VALVE-IN-RING AND VALVEIN-MITRAL ANNULAR CALCIFICATION: RESULTS FROM THE MITRAL TRIAL (2022) (2)
Percutaneous Aspiration Thrombectomy of Thrombus Attached to Left Atrial Surface of a Watchman FLX Device. (2022) (2)
NO TWO SYSTOLES THE SAME: PERSONALIZING TRANSCATHETER HEART VALVE SELECTION FOR TRANSCATHETER AORTIC VALVE REPLACEMENT (2016) (2)
The value of transesophageal echocardiography in predicting immediate and long-term outcome of balloon mitral valvuloplasty: comparison with transthoracic echocardiography. (1994) (2)
Interventions in acute myocardial infarction. (2001) (2)
Abstract 23085: 30-Day Outcomes of Transseptal Transcatheter Mitral Valve Replacement for Failed Surgical Bioprostheses (Mitral Valve-in-Valve): The MITRAL Trial (Mitral Implantation of TRAnscatheter vaLves) (2017) (2)
TCT-83 Lactate and Cardiac Power Output Measurements at 12-24 Hours Reliably Predict Outcomes in Cardiogenic Shock: Insights from the National Cardiogenic Shock Initiative (2018) (2)
SEX-BASED DIFFERENCES IN OUTCOMES AFTER TRANSCATHETER REPAIR OF MITRAL REGURGITATION WITH THE MITRALCLIP SYSTEM (2019) (2)
Six-month Outcomes from the Multicenter, Prospective Study with the Novel PASCAL Transcatheter Valve Repair System for Patients with Mitral Regurgitation in the CLASP Study (2019) (2)
919-14 What is the Ideal Burr Size for Rotablator Atherectomy? (1995) (1)
Multivessel angioplasty versus bypass surgery. A case for PTCA. (1995) (1)
A randomized trial of prevention measures in patients at high risk for contrast nephropathy: initial results of the PRINCE study (1998) (1)
Using 3D-Printed Models to Advance Clinical Care (2019) (1)
PACEMAKER FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT ASSOCIATED WITH INCREASED TRICUSPID REGURGITATION (2019) (1)
738–6 Recanalization of Chronically Occluded Bypass Grafts: The Effect of Angioplasty Site Following Extended Urokinase Infusion on 6 Month Patency (1995) (1)
Cerebrovascular accidents after percutaneous coronary interventions: Incidence, predictors, and outcomes (2003) (1)
Eligibility for use of proximal or distal embolic protection devices during percutaneous intervention for acute myocardial infarction. (2005) (1)
TRANSCATHETER VERSUS SURGICAL AORTIC VALVE REPLACEMENT IN ELDERLY PATIENTS: A PROPENSITY SCORE MATCHED ANALYSIS FROM THE NATIONAL READMISSION DATABASE 2011-2015 (2019) (1)
Responses to the editor RE: McCullough PA, Roberts WC. Peter Andrew McCullough, MD, MPH: An interview with the editor. Am J Cardiol 2014;114:1772-1785. (2015) (1)
Incidence of acquired ventricular septal defect after transcatheter aortic valve replacement: A large single center experience (2021) (1)
Reply: Patient-Specific Computer Modeling for the Planning of Transcatheter Mitral Valve Replacement. (2018) (1)
Arrhythmia: Predicting survival in out-of-hospital cardiac arrest (2000) (1)
A Prospective Multicenter Study to Evaluate Safety and Probable Benefit of a Novel Percutaneous Ventricular Assist Device for Right Ventricular: Failure: The RECOVER RIGHT Study (2015) (1)
Impact of Surgical Consultation on Outcomes in Hemodynamically Supported High-Risk Percutaneous Coronary Intervention: Insights From PROTECT II Randomized Study. (2016) (1)
Determinants of Left Ventricular Functional Recovery After Thrombolytic Therapy and/or Immediate Coronary Angioplasty in Acute Myocardial Infarction (1988) (1)
Distal protection during primary angioplasty: a feasibility and safety study utilizing a novel filter technology. (2006) (1)
Reply: Pre-Emptive Alcohol Septal Ablation Is Feasible and Prevents LVOT Obstruction Post-TMVR. (2019) (1)
The Primary Angioplasty in Myocardial Infarction Studies: An Overview (1998) (1)
In-hospital and Late Outcomes Following Primary Stenting in Acute Myocardial Infarction-Comparison With Primary PTCA (1998) (1)
Frequency, determinants, and clinical implications of angiographically-visible intracoronary thrombus following primary angioplasty for acute myocardial infarction (2002) (1)
TRANSCATHETER MITRAL VALVE-IN-RING IMPLANTATION AFTER FAILURE OF SURGICAL MITRAL RING ANNULOPLASTY (2017) (1)
Aorto-Left Ventricular Fistula From Aortic Pseudoaneurysm After TAVR: Transcatheter Treatment With Multimodality Imaging. (2022) (1)
Transcaval TAVR—What the Radiologist Needs to Know (2015) (1)
Treatment of acute myocardial infarction [1] (1993) (1)
Application of 3D CT image guidance to paravalvular leak repairs (2019) (1)
Percutaneous laser revascularization in patients with chronic total occlusions. (2002) (1)
TCT-431 Socioeconomic disparities in access for Watchman device insertion in patients with atrial fibrillation and at elevated risk of bleeding. (2017) (1)
1000–34 Facilitated Lumen Enlargement by Longitudinal Force Focused Angioplasty (1995) (1)
778-4 Is Primary Angioplasty Less Effective in Patients with Acute Myocardial Infarction Presenting in the Early Morning Hours? (1995) (1)
TCT-129 Age Stratified Analysis for Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation or Septal Myectomy (2019) (1)
Importance of mitral regurgitation inpatients undergoing percutaneous coronaryintervention for acute myocardial infarction (2016) (1)
TCT-98 Percutaneous Right Ventricular Support with Impella RP in Severe Right Ventricular Failure: insights from Impella RP clinical studies (2017) (1)
Primary PTCA results in similar in-hospital outcomes in females and males presenting with acute MI (1996) (1)
Recurrent ventricular fibrillation in a marathon runner during exercise testing. (2000) (1)
Abstract 3689: Genome Wide Association Study of In-stent Restenosis Identifies Multiple Candidate Susceptibility Loci (2006) (1)
Ambulatory blood pressure results of symplicity HTN-3 trial (2014) (1)
Two vessels or not two vessels? That is the question. (2002) (1)
Trans-Caval Impella 5.0: A Bridge to Recovery in Peripartum Cardiomyopathy (2019) (1)
TCT-813 Alcohol Septal Ablation in patients with Left Ventricular Outflow Tract Obstruction after Transcatheter Mitral Valve Replacement for Mitral Annular Calcification (TMVR in MAC). (2016) (1)
TCT-136 Outcomes of Hemodynamic Support with Impella in very high-risk patients undergoing Balloon Aortic Aortic Valvuloplasty: Results From the Global cVAD Registry. (2016) (1)
President's page: i2 Summit 2006: one-stop shopping for interventionalists. (2005) (1)
Primary intervention in acute myocardial infarction: Do bankers' hours suffice, or should we invest our resources elsewhere? (1999) (1)
Impella-assisted balloon aortic valvuloplasty as a bridge to transcatheter aortic valve replacement: non-contrast approach. (2015) (1)
Aqueous oxygen therapy for ST-segment elevation myocardial infarction: AMIHOT trial design and preliminary results (2003) (1)
TCT-127 Prior Coronary Artery Bypass Graft Surgery and Hemodynamically Supported High Risk Percutaneous Coronary Intervention: Observations from The PROTECT II Randomized Trial and The cVAD Registry. (2016) (1)
Role of prolonged intravenous heparin in unstable angina patients prior to coronary angioplasty. (2001) (1)
Transcaval transcatheter aortic valve implantation for severe aortic insufficiency. (2014) (1)
TCT-605 Sex Based Differences in In-Hospital Outcomes of Patients With Cardiogenic Shock Treated With Percutaneous Mechanical Circulatory Support in the United States (2018) (1)
TCT-520 PROspective, Randomized Comparison of 3-Dimensional Computed Tomography Guidance versus TEE data for Left Atrial Appendage Occlusion (PRO3DLAAO) (2017) (1)
Abstract 252: Cost of Hospitalization for Balloon Aortic Valvuloplasty in the US: A 10-Year Contemporary Perspective (2013) (1)
TCT-128 Impact of Gender on Clinical Outcomes of Septal Myectomy Versus Alcohol Septal Ablation for Hypertrophic Cardiomyopathy in the United States (2019) (1)
Reply: Limitations of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Should it Be Performed Outside the Purview of a Clinical Trial? (2016) (1)
SAFETY OF RHYTHM CONTROL AND CARDIOVERSION FOR PATIENTS WITH RECURRENT SYMPTOMATIC ATRIAL FIBRILLATION IN THE ABSENCE OF ANTICOAGULATION FOLLOWING PERCUTANEOUS LEFT ATRIAL APPENDAGE OCCLUSION (2018) (1)
PROTECT I Trial): Initial U.S. Experience in Patients Undergoing High-Risk Percutaneous Coronary Intervention (The (2011) (1)
995-21 Coronary Flow Reserve Does Not Improve After Successful Rotablator Atherectomy and Adjunctive Angioplasty (1995) (1)
Methodological Issues and Their Impact on Conclusions. (2017) (1)
TCT-862 A More Reliable Method for Predicting Neo-LVOT Obstruction after TMVR (2018) (1)
A tale of two pressures: A case of pseudo‐prosthetic mitral valve stenosis (2011) (1)
Emergency Alcohol Septal Ablation for Shock After TAVR (2021) (1)
FEASIBILITY AND SAFETY OF ORBITAL ATHERECTOMY FOR THE TREATMENT OF IN-STENT RESTENOSIS (2019) (1)
INITIAL EXPERIENCE WITH LITHOTRIPSY FOR MITRAL BALLOON VALVULOPLASTY (2022) (1)
Early Experience With Transcatheter Mitral Valve Replacement (1)
Reply: percutaneous access, no matter what! (2015) (1)
Combined intraaortic balloon counterpulsation with synchronized coronary venous retroperfusion: the United States experience. (1994) (1)
869-3 Aqueous oxygen therapy for ST segment elevation myocardial infarction: AMIHOT trial safety report and enrollment completion (2004) (1)
Simultaneous evaluation of myocardial function, viability, and microvascular dysfunction by a new magnetic resonance technique (2003) (1)
The evolution of primary PTCA therapy of acute myocardial infarction: a personal perspective. (1995) (1)
Elevated C-reactive protein in diabetics with acute coronary syndrome: culprit or innocent bystander? (2002) (1)
Left Atrial Venoarterial Extracorporeal Membrane Oxygenation for Patients in Cardiogenic Shock and Acute Aortic Regurgitation. (2022) (1)
Association between Public Reporting of Outcomes and the Use of Mechanical Circulatory Support in Patients with Cardiogenic Shock (2019) (1)
Transcaval access for the emergency delivery of mechanical circulatory support in cardiogenic shock (2019) (1)
Caval-Aortic Access to Allow Transcatheter Aortic Valve Replacement in Patients Otherwise Ineligible : Initial Human Experience (2014) (1)
TCT-123 Impact of Gender and Ischemic Time in Anterior STEMIs With Left Ventricular Unloading and Delayed Reperfusion: A Substudy From the STEMI-DTU Safety and Feasibility Trial (2019) (1)
TCT-189 The Use of Mechanical Circulatory Support Devices during TAVR: A Single Center Experience with Long Term Follow-up (2015) (1)
Interim safety analysis of the beaumont outpatient angioplasty trial (1991) (1)
B-4 | Clinical Outcomes of Patients with Transient Loss of Pulsatility During Hemodynamically Supported High Risk PCI (2022) (1)
Impella Versus Intra-Aortic Balloon Pump for High-Risk PCI: A Propensity-Adjusted Large-Scale Claims Dataset Analysis. (2022) (1)
INFERIOR AND POSTERIOR: UTILIZATION OF 3D PRINT AND COMPUTER AIDED DESIGN TO SPATIALLY MAP OPTIMAL TRANSSEPTAL CROSSING POINT FOR LEFT ATRIAL APPENDAGE OCCLUSION WITH THE WATCHMAN DEVICE (2016) (1)
The year in interventional cardiology. (2007) (0)
Effect of a novel pharmacological strategy to counteract shivering during endovascular cooling for acute myocardial infarction (2003) (0)
TCT-151 Ventricular Septal Rupture Complicating ST-Elevation Myocardical Infarctions: A Nationwide Analysis. (2016) (0)
Abstract 195: Length of Stay in High Risk Percutaneous Coronary Intervention in US: A 5 year Contemporary Experience (2013) (0)
TCT-742 Individual and Regional Variations in Dual Antiplatelet Therapy Dose and Duration in a Large, Randomized International Trial Comparing Two Drug-eluting Stents: Results From PROTECT (2012) (0)
Abstract 18162: Does Transcatheter Aortic Valve Replacement Have Acute Impact on Right Ventricular Function ? (2014) (0)
1062-42 Adverse events in patients with normal renal function are increased with modest increases in creatinine clearance after percutaneous coronary intervention (2004) (0)
Rarity of circumflex culprits in ST-elevation MI is due to relative ECG silence (2002) (0)
Two-year outcomes following percutaneous intervention: Beaumont Angiotensin converting enzyme Genotype and Endpoints Trial (the BAGET trial) (2002) (0)
The Changing Role of PTCA in Patients with Acute Myocardial Infarction (1988) (0)
P5691First series of Impella mechanical circulatory support for takotsubo syndrome with shock (2018) (0)
Inter-hospital transfers in acute myocardial infarction and cardiogenic shock (2020) (0)
CRT-100.38 Shock Protocols May Decrease Racial, Ethnic, and Sex Disparities in Acute Myocardial Infarction and Cardiogenic Shock (2022) (0)
Interventions in acute myocardial infarction. (1986) (0)
Abstract 3065: Gadolinium Does Not Prevent Contrast-Induced Nephropathy (2006) (0)
Abnormal Hemoglobin A1c is Associated with an Increased Rate of Target Vessel Revascularization in Nondiabetic Patients Undergoing Percutaneous Coronary Revascularization (2002) (0)
TCT-501 Echocardiographic Findings of Transcatheter Mitral Valve-in-Valve Therapy VS. Re-do Surgical MVR in Patients with Previous Mitral Prosthetic Valves (2017) (0)
Snow removal as a trigger of sudden cardiac death in men of higher socioeconomic status (2002) (0)
Abstract 53: Automated External Defibrillators Do Not Reduce Time to First Shock in Patients who present with Pulseless Ventricular Tachycardia or Ventricular Fibrillation during In-hospital Cardiac Arrest (2006) (0)
AEROBIC AND CARDIAC DEMANDS OF STAIR CLIMBING IN TRAINED CORONARY PATIENTS (1999) (0)
Snatching Defeat From the Jaws of Victory-Bioprosthetic Valve Dysfunction After Percutaneous Mitral Paravalvular Leak Closure: Salvage by Transcatheter Mitral Valve-in-Valve. (2019) (0)
Primary angioplasty reduces mortality in elderly patients with right ventricular infarction (2003) (0)
Temporal trends in percutaneous treatment for cardiogenic shock due to acute myocardial infarction: have stents and glycoprotein receptor inhibitors improved outcome? (2002) (0)
The editor's roundtable: intracoronary hyperoxemic therapy in acute myocardial infarction. (2009) (0)
TCT-865 Rotational Aortography With CT Reconstruction Can Guide Transcatheter Aortic Valve Replacement And Predict Prosthetic Regurgitation (2012) (0)
The Lariat Device: R.I.P. or Buried Alive. (2018) (0)
SAFETY AND FEASIBILITY OF TRANSCAVAL APPROACH FOR TRANSCATHETER AORTIC VALVE REPLACEMENTS (2022) (0)
Editorial comment: The relentless pursuit of sustained patency after acute myocardial infarction (1996) (0)
The year in interventional cardiology. (2005) (0)
A case of recurrent obstructive thrombosed mechanical mitral valve and the role of thrombolytic therapy (2018) (0)
CARDIAC TROPONIN I, CK–MB AND BNP LEVELS INCREASE ACUTELY AFTER PERCUTANEOUS LEFT ATRIAL APPENDAGE SUTURE CLOSURE WITH THE LARIAT DEVICE (2013) (0)
Differences in outcome after angioplasty for acute myocardial infarction: The left anterior descending artery vs. the right coronary artery (1996) (0)
1060-81 Multiple complex plaques in unstable saphenous vein grafts (2004) (0)
TCT-679 Effect of Operator Volume on Complications during Percutaneous Closure of Atrial Septal Defects and Patent Foramen Ovale - A US Perspective of the Last Decade. (2013) (0)
A prolonged intracoronary infusion of urokinase for chronic total occlusions: case reviews. (1995) (0)
Intraoperative identification and management of graft failure after minimally invasive coronary bypass surgery (1998) (0)
Red Cell Shearing between Transcatheter Heart Valves? Acute Hemolysis after Emergency TAVR-in-TAVR (2020) (0)
Use of Alcohol Septal Reduction Therapy to Facilitate Transcatheter Mitral Valve Replacement (2021) (0)
Transcatheter Mitral Valve Therapy: Repair and Replacement (2019) (0)
Percutaneous Transluminal Coronary Angioplasty Improves Survival (2005) (0)
TCT-396 Association of Peripheral Artery Disease with In-hospital Outcomes after Endovascular Transcatheter Aortic Valve Replacement (2018) (0)
TCT-786 In-Hospital Outcomes of balloon aortic valvuloplasty and percutaneous coronary intervention during the same hospitalization in the US (2014) (0)
Effect of Race on Clinical Outcomes Following Hemodynamically Supported High-Risk Percutaneous Coronary Intervention (2023) (0)
AR INDEX POST IMPLANT OF TWO DIFFERENT TRANSCATHETER AORTIC VALVES (2013) (0)
PREDICTORS OF NET ADVERSE CLINICAL EVENTS POST BALLOON AORTIC VALVULOPLASTY: RESULTS FROM THE BRAVO (EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES) STUDY (2012) (0)
CARDIOVASCULAR RESPONSE TO SKYDIVING (1999) (0)
Lesion length assessment using a new vessel caliper (2003) (0)
Baseline Morphology of 158 Saphenous Vein Bypass Graft Leslons Treated by Transluminal Extraction Coronary Atherectomy (2005) (0)
Left ventricular remodeling is the most common cause of systolic dysfunction after acute myocardial infarction: Findings from the stent-PAMI study (2003) (0)
Initial in‐human experience with the conveyor cardiovascular system for the delivery of large profile transcatheter valve devices (2021) (0)
TCT CONNECT-29 Vasopressors Have Independent Adverse Impact on Survival in Patients With Acute Myocardial Infarction Cardiogenic Shock (2020) (0)
Gender is an independent predictor of both in-hospital and one-year outcomes following primary intervention for acute myocardial infarction (2002) (0)
TCT-124 Predictors of the Need for Continuous Impella Support in High Risk Percutaneous Coronary Intervention. (2016) (0)
Issues in Management of Acute Coronary Syndromes: Effects of Bleeding (2007) (0)
DIGITAL RADIOGRAPHIC TECHNIQUE FOR VISUALIZATION AND QUANTITATION OF REGIONAL MYOCARDIAL PERFUSION. (1983) (0)
Primary Percutaneous Coronary Intervention (2008) (0)
Utility of ECG-gated computed tomography angiography for the improved diagnosis of bicuspid aortic valve disease prior to transcatheter aortic valve replacement (2020) (0)
What Role Does Mannitol Play in Preventing Contrast Nephropathy? a Prospective Analysis (1998) (0)
Renal stenting preserves single kidney GFR compared to medical therapy in patients with renal artery stenosis: fourteen-month follow-up (2002) (0)
Utility Of Standardized Pre-CTA Hydration Protocol On Patients Referred For Transcatheter Aortic Valve Replacement. (2020) (0)
TCT-240 Aspiration Thrombectomy during ST-Elevation Myocardial infarction: An updated Systematic Review and Meta-Analysis of Randomized Controlled Trials- 2015 (2015) (0)
Intervention for acute myocardial infarction (2013) (0)
PREDICTORS OF LATE BLEEDING IN THE TAVR POPULATION (2017) (0)
ELECTROCARDIOGRAPHIC RESPONSES TO DEER HUNTING VIA HOLTER MONITORING 121 (1996) (0)
1018-48 Comparative Results of Extraction Atherectomy (TEC) in Vein Graft Lesions with and without Thrombus (1995) (0)
Systemic inflammation: Independent predictor of contrast induced nephropathy (2003) (0)
Targeted exclusion of proximal obstructive coronary disease on coronary computed tomography angiography for deferral of routine invasive coronary angiography prior to transcatheter aortic valve replacement (2020) (0)
Balloon-Assisted Valve Tracking: Atraumatic Retrieval of a Ventricularized Transcatheter Aortic Valve Prosthesis. (2020) (0)
The year in interventional cardiology. (2010) (0)
1022-107 Outcome of Different Reperfusion Strategies in Thrombolytic “Eligible” versus “Ineligible” Patients with Acute Myocardial Infarction (1995) (0)
179 - Despite Higher Morbity and Mortality Risk Women Had Similar Outcomes and Improvement in Heart Failure as Men in Complex PCI with Impella Hemodynamic Support (2017) (0)
TCT CONNECT-172 Clinical Features and Outcomes of Acute Myocardial Infarction and Cardiogenic Shock Patients Treated With Impella: Early Compared With Recent Experience (2020) (0)
SAFETY AND EFFECTIVENESS OF MANTA VASCULAR CLOSURE DEVICE AFTER LARGE BORE ARTERIAL ACCESS FOR MECHANICAL CIRCULATORY SUPPORT - INITIAL REAL WORLD EXPERIENCE (2020) (0)
Pitfalls and Practical Approach to the Use of Imaging Techniques in Developing Clinical Strategies (1997) (0)
The relentless pursuit of sustained patency after acute myocardial infarction. (1996) (0)
TCT-444 The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry (2013) (0)
Non‐coaptation of an implanted caval valve leaflets for severe tricuspid regurgitation: Rethinking the concept of “Eustachian ridge?” (2021) (0)
Lack of benefit of stenting compared to balloon angioplasty for native coronary stenoses in diabetics (1998) (0)
336SUPRASTERNAL APPROACH TAVR AVOIDS THORACOTOMY: FIRST IN MAN EXPERIENCE (2014) (0)
Clinical and angiographic predictors of abnormal doppler-derived flow in the infarct related artery after primary angioplasty for acute myocardial infarction (2002) (0)
Overview of the i2 (Innovation in Intervention) Summit 2006 (2006) (0)
TCT-589 Meta-analysis of Early Initiation of Impella in Acute Myocardial Infarction and Cardiogenic Shock (2017) (0)
Safety and Feasibility of Transcaval Aortic Valve Replacement with the LOTUS Edge System (2020) (0)
NOTCH1 IS ASSOCIATED WITH THE DEVELOPMENT OF TRI-LEAFLET CALCIFIC AORTIC STENOSIS (2014) (0)
RATES OF ANTICOAGULATION FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH ATRIAL FIBRILLATION (2018) (0)
Mitral valve perforation from aortic insufficiency. (2013) (0)
INCREASED RISK OF PERIOPERATIVE ISCHEMIC STROKE IN PATIENTS WHO UNDERGO NON-CARDIAC SURGERY WITH PREEXISTING PATENT FORAMEN OVALE (2019) (0)
Abstract 331: Effect of Operator and Hospital Experience on Mortality for Balloon Aortic Valvuloplasty (2013) (0)
The year in interventional cardiology. (2009) (0)
Influence of Balloon Angioplasty on Heart Rate Variability in Patients with Coronary Artery Disease (1999) (0)
THERAPY AND PREVENTION (2005) (0)
Three-Dimensional CT Planning for Cerebral Embolic Protection in Structural Interventions. (2020) (0)
OUTCOMES AND THEIR PREDICTORS IN ACUTE TRANSCATHETER AORTIC HEART VALVE-IN-TRANSCATHETER AORTIC HEART VALVE THERAPY (2017) (0)
Why do smokers have a better prognosis with acute myocardial infarction? Insights from the PAMI-2 trial (1996) (0)
TRANSSEPTAL ANTEGRADE TRANSCATHETER AORTIC VALVE REPLACEMENT FOR NO–ACCESS OPTION PATIENTS: A CONTEMPORARY EXPERIENCE (2013) (0)
Persistent native aortic valve function after transcatheter aortic valve replacement. (2013) (0)
Drug-Eluting Stents Costs Versus Clinical Benefit EVIEW : E XPERT (2003) (0)
Prior Coronary Artery Bypass Graft Portends High Risk in STEMI Patients Treated With Primary Percutaneous Coronary Intervention (2009) (0)
Interventional Cardiovascular Medicine: Principles and Practice, 2nd edition (2003) (0)
LONG-TERM OUTCOMES OF TRANSCATHETER MITRAL VALVE REPLACEMENT USING A BALLOON EXPANDABLE VALVE (2020) (0)
Abstract 305: Cost of Hospitalization for High Risk Percutaneous Coronary Intervention in the US: A 5-Year Contemporary Perspective (2013) (0)
Advantages of an early invasive approach in acute coronary syndromes. (2003) (0)
Response by Alqarqaz et al to Letter Regarding Article, "Effects of Impella on Coronary Perfusion in Patients With Critical Coronary Artery Stenosis". (2019) (0)
Baseline left-ventricular function during frequent ventricular or atrial ectopic beats: concise communication. (1982) (0)
EAR IN CARDIOLOGY SERIES he Year in Interventional Cardiology illiam (2016) (0)
Left Ventricular Remodeling After Anterior-STEMI PCI: Imaging Observations in the Door-to-Unload (DTU) Pilot Trial. (2022) (0)
Abstract 5611: Mortality after Acute Non-Culprit Coronary Intervention in STEMI: Insights from APEX AMI (2008) (0)
A prospective study of large vs. small burrs: Intravascular ultrasound findings in the coronary angioplasty and rotablator atherectomy trial (CARAT) (1996) (0)
ntracoronary Fibrin-Specific hrombolytic Infusion Facilitates Percutaneous ecanalization of Chronic Total Occlusion (2016) (0)
Multiple complex unstable plaques associated with systemic inflammation and adverse cardiovascular outcomes (2003) (0)
TCT-875 Frailty is a Major Determinant of Length of Stay After Transcatheter Aortic Valve Replacement (2012) (0)
CHALLENGES IN ACCESS: SOCIOECONOMIC AND DEMOGRAPHIC DISPARITIES IN PATIENTS RECEIVING TRANSCATHETER AORTIC VALVE REPLACEMENT FOR SEVERE AORTIC STENOSIS (2015) (0)
1081-59 Target vessel revascularization during the first month after bare metal coronary stenting: Clinical indications and angiographic findings (2004) (0)
CT Planning for TMVR and Predicting LVOT Obstruction (2021) (0)
720-2 Predictors of Acute Complications After Percutaneous Coronary Revascularization with New Devices (1995) (0)
SEX DIFFERENCES IN IMPELLA SUPPORTED HIGH RISK PERCUTANEOUS CORONARY INTERVENTION OUTCOMES (2023) (0)
ON–LABEL AND OFF–LABEL USE OF TRANSCATHETER HEART VALVES IN INOPERABLE AORTIC STENOSIS PATIENTS: EARLY CLINICAL EXPERIENCE IN THE UNITED STATES (2013) (0)
TCT-237 Comparison of an Innovative Hybrid Closure Technique versus Conventional Vascular Closure Strategy in Large Bore Access during Mechanical Hemodynamic Support for High Risk Percutaneous Coronary Intervention (2017) (0)
1043-44 Identifying patients at risk for ischemia-driven target vessel revascularization after primary percutaneous coronary intervention: Lessons from the primary angioplasty in myocardial infarction (PAMI) trials (2004) (0)
Outcome of Cardiac Tamponade Complicating Percutaneous Coronary Intervention (2002) (0)
D-3 | Association of Relative Left Ventricular Outflow Tract Area During Systole with Post-transcatheter Aortic Valve Implantation Insufficiency (2022) (0)
An Analysis of Determinants of Improvement: Systolic Left Ventricular Function After Reperfusion Therapy for Acute Myocardial Infarction (1993) (0)
TCT-68 The use of Percutaneous Left Ventricular Assist Device vs Intra-aortic Balloon Pump for Hemodynamic Support During High Risk PCI (2012) (0)
Aortic Valve Area and Prosthesis-Patient Mismatch Estimated by Echocardiography Versus Computed Tomography for Transcatheter Aortic Valve Replacement (2022) (0)
A Transcatheter Valve for All Cardiac Positions (2017) (0)
818-5 Percutaneous transfemoral coronary and peripheral procedures via aortofemoral synthetic vascular grafts: A review of 123 diagnostic and interventional cases (2004) (0)
600.57 Finding the Unknown: Decrease in Left Atrial Appendage Velocity as a Surrogate Marker of Successful MitraClip Implantation in Patients With and Without Atrial Fibrillation (2019) (0)
Safety profile of glycoprotein IIb/IIIa inhibitors in octogenerians (2002) (0)
TCT-484: Cost-effectiveness and Clinical Outcomes of Impella Hemodynamic Support Compared with Intra- Aortic Balloon Pump in High Risk Patients Receiving PCI: Results from the PROTECT II Trial (2016) (0)
TRANSSEPTAL DELIVERY FOR MITRAL VALVE IN VALVE PROCEDURES USING AN APICAL RAIL: TECHNIQUE DESCRIPTION AND INITIAL RESULTS (2016) (0)
TCT-445 Patients with 3-vessel Coronary Artery Disease and Impaired LVEF undergoing PCI with Impella 2.5 Hemodynamic Support Have Improved 90-Day Outcomes Compared to Intra-Aortic Balloon Pump: A Substudy of The PROTECT II Trial (2013) (0)
News Capsules: Angiography plus IV thrombolysis: An imperfact mix? (1993) (0)
Reply: High-Risk Percutaneous Coronary Interventions: First, Do No Harm. (2016) (0)
SEMINAR ON BALLOON AORTIC VALVULOPLASTY-VI Efficacy of Multiple Balloon Aortic Valvuloplasty Procedures (2010) (0)
TCT CONNECT-181 A Propensity Matched Analysis of Impella Use From a Large-Scale Claims Data: Influence of Analytic Methodology on Clinical Outcomes (2020) (0)
Unjailing of the septal perforator using a rotational atherectomy device prior to alcohol septal ablation in a patient with symptomatic hypertrophic obstructive cardiomyopathy (2014) (0)
7 VALIDATION OF A PREDICTIVE RISK SCORE FOR CONTRAST-INDUCED NEPHROPATHY FOLLOWING PERCUTANEOUS CORONARY INTERVENTION (2005) (0)
Impact of spontaneous reperfusion in diabetics with acute myocardial infarction (2007) (0)
Preclosure of large bore venous access sites in patients undergoing transcatheter mitral replacement and repair (2022) (0)
Unprotected discharge: absence of stroke prevention strategies in patients with atrial fibrillation admitted for bleeding (2020) (0)
Suboptimal platelet inhibition with tirofiban in patients undergoing coronary intervention for unstable angina (2002) (0)
Transaortic Valve Gradient Determined by a Dual Lumen Pressure Monitoring Catheter (1990) (0)
Abstract 3162: Dynamic mortality modeling in PCI-treated ST-elevation Myocardial Infarction: Implications for Clinical Decision Making (2007) (0)
Long term patency and incidence of restenosis after primary angioplasty therapy of acute myocardial infarction (1991) (0)
Impact of Prior Coronary Artery Bypass Grafting in Patients ≥ 75 Years old Presenting with Acute Myocardial Infarction (From the National Readmission Database). (2020) (0)
Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty (2005) (0)
TCT-100 Effect of Intra cardiac echocardiography and yearly operator volume on Length of Stay and Cost of Care for Percutaneous Closure of Atrial Septal Defects and Patent Foramen Ovale: A Perspective of Last Decade (2013) (0)
Special Report (2022) (0)
TCT-69 Evaluating The Learning Curve In A Clinical Trial Using A New Percutaneous Left Ventricular Support System. Observations From The PROTECT II Trial (2014) (0)
TCT-697 Comparison of Outcomes of Transcatheter Aortic Valve Replacement plus Percutaneous Coronary Intervention versus Transcatheter Aortic Valve Replacement Alone in the United States. (2016) (0)
Predictors of new renal dialysis after percutaneous coronary intervention (2003) (0)
1023-113 Differential Effects of Long-term Beta-Blocker Therapy Following Thrombolysis versus Primary Angioplasty (1995) (0)
The hemodynamic effects of coronary reperfusion in right ventricular infarction (1991) (0)
Letter by O'Neill and Burkhoff Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support". (2020) (0)
Abstract 16998: Impact of Annual Operator Volume on Percutaneous Coronary Intervention Outcomes: A United States Experience From 2,243,209 procedures (2013) (0)
Six-month and one-year outcomes with the PASCAL transcatheter valve repair system for patients with mitral regurgitation from the multicentre, prospective CLASP study (2020) (0)
Clinical Outcomes of Acute Myocardial Infarction Cardiogenic Shock: A Contemporary Single Center Experience (2018) (0)
B-8 | Door to Impella Placement in Acute Coronary Syndrome Complicated by Cardiogenic Shock: An Updated Meta-Analysis (2022) (0)
TCT-778 A Comparison of the Complications and Mortality between the Transapical and Transfemoral Accesses for Transcatheter Aortic Valve Replacement with Edwards SAPIEN valve: PARTNER Trial vs Worldwide Studies and Registries (2014) (0)
Primary angioplasty leads to a low incidence of adverse outcomes in patients with the substrate for right ventricular infarction (1996) (0)
Low bone mineral density predicts significant coronary artery disease at cardiac catheterization (2003) (0)
The Effect of Diabetes and Revascularization Technique on Early Outcomes (1998) (0)
PET myocardial blood flow and coronary doppler flow velocity are highly correlated and predict post-infarction perfusion in patients with TIMI 3 flow (1995) (0)
Elevated Central Venous Pressure As A Trigger For Right Heart Failure Evaluation In Patients Receiving Left-sided Mechanical Support For Cardiogenic Shock (2020) (0)
The evolution of oral antiplatelet therapy. (1999) (0)
TCT-876 Decreasing B – Type Natriuretic Peptide Predicts Survival After Transcatheter Aortic Valve Replacement (2012) (0)
TCT-224 High-Risk Chronic Total Occlusion Percutaneous Coronary Interventions Assisted With Tandem Heart (2019) (0)
The DELTA MI ( Direct Inhibition of Protein Kinase Enyzme to Limit Total Infarct Size in Acute Myocardial nfarction ) trial (2008) (0)
Reply: Cardiogenic Shock Management Will Never Be All or None. (2020) (0)
TU-E-I-611-06: A Novel Shielding System That May Eliminate the Need for Lead Apparel During Fluoroscopic Procedures (2005) (0)
INCIDENCE OF STROKE IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT USING EDWARDS SAPIEN VALVE FOR CRITICAL AORTIC STENOSIS. META–ANALYSIS COMPARING TRANSFEMORAL VERSUS TRANSAPICAL APPROACH (2013) (0)
Angioplasty therapy of acute myocardial infarction in the real world. (1995) (0)
UTILIZATION OF CORONARY INTERVENTIONS AND OUTCOMES IN WEEKEND VERSUS WEEKDAY ADMISSIONS FOR STEMI COMPLICATED BY CARDIOGENIC SHOCK (2020) (0)
OUTCOMES OF IMPELLA ASSISTED PERCUTANEOUS BALLOON AORTIC VALVULOPLASTY IN VERY HIGH RISK SEVERE AORTIC STENOSIS PATIENTS (2016) (0)
1043-64 Adverse outcomes in women undergoing percutaneous coronary intervention (2004) (0)
Pacemaker following transcatheter aortic valve replacement and tricuspid regurgitation: A single‐center experience (2021) (0)
956-116 The Reperfusion Strategy Does Affect Outcome When Nonsmokers Present with Acute Myocardial Infarction: A PAMI Substudy (1995) (0)
14. AND PRACTICAL APPROACH TO THE (1997) (0)
Are Residual Stenoses After Excimer Laser An ioplasty and Coronary Atherecto y e to Inefficient or a Devices ? Comparison it Balloon (2016) (0)
Bilateral Transbrachial Intracardiac Echocardiography-Guided Patent Foramen Ovale Closure in Patient With Bilateral Deep Vein Thrombosis. (2022) (0)
“Transcaval First” Alternative Access Strategy For Transcatheter Aortic Valve Replacement Guided By Computed Tomography Angiography (2020) (0)
RECURRENT VENTRICULAR FIBRILLATION IN A MARATHON RUNNER DURING AN EXERCISE STRESS TEST (1999) (0)
Left Atrial Appendage Occlusion With the LAmbre Device: First-in-Human in the United States. (2021) (0)
Comparative differences of mitral valve‐in‐valve implantation: A new mitral bioprosthesis versus current mosaic and epic valves (2021) (0)
IMPACT OF VASCULAR CLOSURE WITH THE PRE-CLOSURE TECHNIQUE ON ADVERSE EVENTS IN PATIENTS UNDERGOING TRANSFEMORAL BALLOON AORTIC VALVULOPLASTY: RESULTS FROM A 2-CENTER registry (2012) (0)
STROKE RATES IN VARIOUS ANTIPLATELET AND ANTICOAGULANT REGIMENS FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT (2018) (0)
Shock Protocols May Decrease Racial, Ethnic, and Sex Disparities in Acute Myocardial Infarction and Cardiogenic Shock (2022) (0)
Hypothermia for Acute Myocardial Infarction (2004) (0)
One-year insulin-dependent diabetic outcomes in the Taxus Cypher — “What's Your Real-World Experience” study (2007) (0)
Bradycardia, hypotension, and chronotropic incompetence are common with acute proximal versus distal RCA occlusion (2002) (0)
Cost analysis of different management strategies for myocardial infarction (1996) (0)
CRT-817 Intentional Right Atrial Exit For Microcatheter Infusion Of Pericardial Carbon Dioxide Or Iodinated Contrast To Facilitate Sub-xiphoid Access (2015) (0)
Association Between the Use of Invasive Hemodynamic Monitoring and Outcomes with Percutaneous Left Ventricular Support: A Call for Standardization? (2017) (0)
Coronary angioplasty for stent restenosis. (1994) (0)
Acute Cardiac Unloading and Recovery Proceedings of the first annual Acute Cardiac Unloading and REcovery ( A-CURE ) (2017) (0)
Beta-Blockers in Myocardial Infarction ustained Ventricular Tachycardia or ibrillation in the Cardiac Catheterization aboratory Among Patients Receiving rimary Percutaneous Coronary Intervention ncidence , Predictors , and Outcomes (2016) (0)
The role of enoxaparin in interventional management of patients with acute coronary syndromes. (2003) (0)
811-4 Coronary Doppler Flow Velocity and PET Myocardial Blood Flow are Highly Correlated and Predict Post-Infarction Perfusion In Patients with TIMI 3 Flow (1995) (0)
Does prior angina predict outcomes following acute myocardial infarction? Testing the relevance of ischemic pre-conditioning in the era of primary angioplasty (2002) (0)
CRT-700.10 Aortic Valve Area and Prosthesis-Patient Mismatch Estimated by Echocardiography Versus Computed Tomography for Transcatheter Aortic Valve Replacement (2022) (0)
TCT-681 Effect of Intra-Cardiac Echocardiography on Complications of Percutaneous Left Atrial Appendage Closure: A 5 Year Perspective of the United States. (2013) (0)
TCT-773 The Prognostic Significance of Changes in B-type Naturetic Peptide (BNP) after Transcatheter Aortic Valve Replacement (TAVR): THE PARTNER I EXPERIENCE (2013) (0)
CRT-700.34 Short-Term Outcomes Among Aortic Valve Stenosis Patients Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention (2023) (0)
TCT-20 Use of a Percutaneous Left Ventricular Assist Device for High Risk Percutaneous Coronary Interventions. Clinical Trial versus Real World Experience (2015) (0)
Transseptal puncture through an Amplatzer Atrial Septal Occluder for edge-to-edge repair with MitraClip NTr system. (2020) (0)
ONE YEAR OUTCOME AFTER PERCUTANEOUS CLOSURE OF PARAVALVULAR LEAKS OF EDWARDS-SAPIEN TRANSCATHETER AORTIC VALVE (2014) (0)
UTILIZATION AND MORTALITY TRENDS FOR BALLOON MITRAL VALVULOPLASTY IN THE UNITED STATES: AN EIGHT–YEAR PERSPECTIVE (2013) (0)
TCT CONNECT-5 Six-Month and One-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study (2020) (0)
Prediction of In-hospital Survival After Sudden Cardiac Death: Derivation and Validation of a Clinical Model (1998) (0)
TCT-178 Temporal trends in the utilization of Right Heart Catheterization (RHC) among recipients of Percutaneous Ventricular Assist Device (PVAD) in Acute Myocardial Infarction complicated by Cardiogenic Shock (AMI-CS) (2018) (0)
Clinical and angiographic predictors of adverse cardiac events after rotablator atherectomy (1996) (0)
SEMINAR ON BALLOON AORTIC VALVULOPLASTY--IV (2010) (0)
Re‐instituting a live cardiology meeting without symptomatic COVID‐19 transmission (2021) (0)
rocedural Success Versus Clinical Risk Status n Determining Discharge of Patients After rimary Angioplasty for Acute Myocardial Infarction (2016) (0)
PCI Guideline Update (2005) (0)
Outcome after acute myocardial infarction in young patients: analysis of the PAMI database (2002) (0)
TO BLEED OR TO CLOT: STROKE PREVENTION STRATEGIES IN PATIENTS WITH ATRIAL FIBRILLATION OR FLUTTER AFTER BLEEDING (2020) (0)
100.32 Left Ventricular Unloading and Delayed Reperfusion Reduces Infarct Size to a Greater Extent in Women With Large Anterior STEMi. A Substudy From the DTU-STEMI Safety And Feasibility Trial (2019) (0)
Abstract 6023: The Need for Blood Transfusion Is an Independent Predictor of Incident Cardiovascular Events and All-Cause Mortality among Patients Undergoing Percutaneous Coronary Intervention (2008) (0)
1138-44 Platelet glycoprotein IIIa genotype is not a risk factor for target vessel revascularization following percutaneous coronary intervention (2004) (0)
Edwards SAPIEN in Native Mitral Annular Calcification (MAC) (2021) (0)
Poor one year prognosis in acute myocardial infarction patients with saphenous vein grafts as the infarct related vessel treated by primary balloon angioplasty (2002) (0)
Adverse Outcomes Prior to Hospital Discharge After Primary Stenting for Acute Myocardial Infarction Are Often Predictable, and Related to Correctable Technical Factors (1998) (0)
TCT CONNECT-185 Early Impella RP Support Improves Outcomes for Acute Right Ventricular Failure Complicated by Cardiogenic Shock (2020) (0)
TCT CONNECT-27 Impact of Prior Coronary Artery Bypass in Elderly Patients Presenting With Acute Myocardial Infarction (2020) (0)
UTILIZATION AND MORTALITY TRENDS FOR BALLOON AORTIC VALVULOPLASTY IN THE UNITED STATES: A 8 YEAR PERSPECTIVE (2013) (0)
Abstract 1272: Vascular Endothelium Growth Factor-165 Gene Therapy Promotes Cardiomyogenesis in Reperfused Myocardial Infarction (2006) (0)
TCT-417 Left Ventricular Assist Improves 90 Day Outcomes With Unprotected Left Main Coronary Intervention: Analysis From The Protect II Trial (2013) (0)
Utility of cerebral embolic protection in non-TAVR transcatheter procedures. (2021) (0)
Death and dialysis risk after transcatheter aortic valve replacement (2017) (0)
THIRTY-DAY READMISSIONS AFTER PERCUTANEOUS CORONARY INTERVENTION IN ACUTE MYOCARDIAL INFARCTION COMPLICATING CARDIOGENIC SHOCK (2019) (0)
Compatibility of Novel Cardiogenic Shock Phenotypes from the Cardiogenic Shock Working Group (CSWG) with the SCAI Staging System (2021) (0)
The salutary effect of prior beta blocker therapy on clinical outcomes following primary angioplasty for acute myocardial infarction: a pooled analysis from the Primary Angioplasty in Myocardial Infarction (PAMI:1), PAMI:2, and stent:PAMI trials (2002) (0)
The role of fibrinolytic therapy in the management of chronic total occlusions (2007) (0)
Long-term outcome in patients with acute myocardial infarction undergoing primary percutaneous intervention: a pooled analysis of the primary angioplasty in myocardial infarction trials (2002) (0)
Temporal trends of one-year reinfarction and mortality rates following primary angioplasty in high-risk acute myocardial infarction patients (2003) (0)
TCT CONNECT-347 Overexpansion of Balloon-Expandable Aortic Transcatheter Heart Valves in the Mitral Valve Position (2020) (0)
Should coronary angiography be the gold standard. A study correlating thallium myocardial scintigraphy, translesional pressure gradient and percent stenosis (1985) (0)
MYOCARDIAL INFARCTION Analysis of the Relative Costs and Effectiveness of Primary Angioplasty Versus Tissue-Type Plasminogen Activator: The Primary Angioplasty in Myocardial Infarction (PAMI) Trial (2016) (0)
Benefits of adjunctive urokinase treatment during angioplasty (1991) (0)
Reply (2019) (0)
Trans‐caval aspiration artherectomy/thrombectomy of large mobile plaques and thrombi in aortic arch and descending aorta (2022) (0)
Unmasking right ventricular failure in cardiogenic shock: The importance of serial hemodynamics (2021) (0)
THE USE OF HEMODYNAMIC SUPPORT IN OCTOGENERIAN PATIENTS DURING HIGH RISK PERCUTANEOUS CORONARY INTERVENTIONS (2014) (0)
100.25 Left Ventricular Unloading and Delayed Reperfusion Reduces Infarct Size in Large Anterior STEMI: A Substudy From the DTU-STEMI Safety and Feasibility Trial (2019) (0)
TCT-636 International experience with Impella mechanical circulatory support for Takotsubo syndrome with shock (2018) (0)
iagnostic Accuracy of oninvasive Coronary Angiography sing 64-Slice Spiral Computed Tomography (2005) (0)
TCT CONNECT-150 Real World Outcomes With Small (20-mm) Balloon Expandable Sapien 3 Valves Compared to Larger Valves (23-, 26-, and 29-mm) (2020) (0)
TCT-27 Left ventricular function following higher-risk percutaneous coronary intervention performed with hemodynamic support (2018) (0)
Is operator interpretation or core lab analysis more accurate in predicting in-hospital adverse events after primary PTCA? (1998) (0)
Characteristics and outcomes of patients presenting with acute myocardial infarction and cardiogenic shock during COVID‐19 (2022) (0)
Impact of Age in Acute Myocardial Infarction Cardiogenic Shock: Insights From the National Cardiogenic Shock Initiative (2021) (0)
Disparate clinical outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction: is diabetes mellitus an independent predictor of poor outcome? (2002) (0)
Percutaneous Retrieval of an Aortic Valve Vegetation Causing Severe Regurgitation and Cardiogenic Shock. (2023) (0)
TCT CONNECT-184 Impact of Sex and Timing of Impella Support in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock (2020) (0)
Circadian fluctuations in thrombogenicity in patients undergoing primary angioplasty for acute myocardial infarction (2003) (0)
Procedural and mid-term outcomes of coronary protection during transcatheter aortic valve replacement in patients at-risk of coronary occlusion: Insight from a single-centre retrospective analysis. (2020) (0)
768-4 What is Unique About the Infarct Related Artery and How Do These Features Influence Success During Direct PTCA for AMI (1995) (0)
TCT-758 The future of heart pump technology: Hemodynamic monitoring of patients on temporary MCS without additional invasive catheters (2018) (0)
Percutaneous Coronary Rotational Atherectomy: The William Beaumont Hospital Experience (1992) (0)
Account of the First Transcatheter Aortic Valve Replacement in North America. (2022) (0)
The "Snare-and-Anchor" Technique to Rescue Frozen Mechanical Mitral Valve Leaflet After Transcatheter Aortic Valve Replacement. (2020) (0)
TCT-785 Comparison of 30-day Major Vascular Complications between Transfemoral and Transapical Accesses in Transcatheter Aortic Valve Replacement: an Updated Meta-Analysis using Standardized Definitions (2014) (0)
TCT-325 Proper balloon sizing for optimal bridging aortic valvuloplasty therapy in patients awaiting Transcatheter Aortic Valve Replacement (2015) (0)
Cardiogenic Shock Management Should Be a Team Sport. (2021) (0)
TCT CONNECT-176 Diastolic Suction Alarms Are an Early Marker for Right Ventricular Failure in the Setting of Left Ventricular Mechanical Circulatory Support (2020) (0)
100.49 Mechanical Circulatory Support Prior to Elective High-Risk Percutaneous Coronary Intervention (2019) (0)
The influence of baseline thrombocytopenia on the outcomes of percutaneous coronary interventions (2003) (0)
Devices for Myocardial Preservation (2005) (0)

This paper list is powered by the following services:

William W. O’neill's Academic­Influence.com Rankings

William W. O’neill's Degrees

Why Is William W. O’neill Influential?

William W. O’neill's Published Works

Published Works

William W. O’neill's AcademicInfluence.com Rankings